10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington D.C. 20549

Form 10-Q

☒ Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

For the Quarterly Period ended March 31, 2023

☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Commission file number: 000-27866

374WATER INC.

(Exact name of Registrant as specified in its charter)

Delaware	88-0271109
(State or other jurisdiction of incorporation or organization)	(IRS Employer Identification No.)

701 W Main Street, Suite 410

Durham, NC 27701

(Address of principal executive offices)

(919) 888-8194

(Registrant’s telephone number including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, par value $0.0001	SCWO	The Nasdaq Capital Market LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the past 12 months (or for shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☒ Yes  ☐ No

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). ☒ Yes  ☐ No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company.

☐	Large accelerated filer	☐	Accelerated filer
☐	Non-accelerated Filer	☒	Smaller reporting company
		☒	Emerging Growth Company

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ☐ Yes ☒ No

State the number of shares outstanding of each of the issuer’s classes of common equity, as of the latest practicable date: As of May 8, 2023, the issuer had 129,027,819 shares of common stock outstanding.

Index to Form 10-Q

		Page
PART I	FINANCIAL INFORMATION
Item 1.	Condensed Consolidated Financial Statements (Unaudited)	3
	Condensed Consolidated Balance Sheets at March 31, 2023 (Unaudited) and December 31, 2022	3
	Condensed Consolidated Statements of Operations for the three months ended March 31, 2023 and 2022 (Unaudited)	4
	Condensed Consolidated Statements of Changes in Stockholders’ Equity (Deficit) for the three months ended March 31, 2023 and 2022 (Unaudited)	5
	Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2023 and 2022 (Unaudited)	6
	Notes to Unaudited Condensed Consolidated Financial Statements	7
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	19
Item 3.	Quantitative and Qualitative Disclosures about Market Risk	22
Item 4.	Controls and Procedures	22
PART II	OTHER INFORMATION
Item 1.	Legal Proceedings	23
Item 1A.	Risk Factors	23
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	23
Item 3.	Defaults upon Senior Securities	23
Item 4.	Mine Safety Disclosures	23
Item 5.	Other Information	23
Item 6.	Exhibits	24
SIGNATURES		25

2

Cautionary Note Regarding Forward-Looking Information

This Form 10-Q contains certain statements related to future results of the Company that are considered “forward-looking statements'' within the meaning of the Private Litigation Reform Act of 1995. Actual results may differ materially from those expressed or implied as a result of certain risks and uncertainties, including, but not limited to, changes in political and economic conditions; interest rate fluctuation; competitive pricing pressures within the Company’s market; equity and fixed income market fluctuation; technological changes; changes in law; changes in fiscal, monetary, regulatory, and tax policies; monetary fluctuations as well as other risks and uncertainties detailed elsewhere in this Form 10-Q or from time-to-time in the filings of the Company with the Securities and Exchange Commission. Such forward-looking statements speak only as of the date on which such statements are made, and the Company undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date on which such statement is made or to reflect the occurrence of unanticipated events.

PART I FINANCIAL INFORMATION

Item 1. Condensed Consolidated Financial Statements

374Water Inc. and Subsidiaries

Condensed Consolidated Balance Sheets

March 31, 2023 (Unaudited) and December 31, 2022  

	2023			2022
Assets
Current Assets:
Cash	$	9,153,161		$	4,046,937
Accounts receivable, net of allowance of $191 and $0		26,188			—
Unbilled accounts receivable		1,672,454			918,164
Other accounts receivable		308,374			—
Inventory		1,788,019			1,660,710
Investments		1,960,761			1,944,464
Prepaid expenses		130,170			153,455
Total Current Assets		15,039,127			8,723,730
Long-Term Assets:
Equipment, net		140,857			143,079
Intangible asset, net		1,035,817			1,050,022
Total Long-Term Assets		1,176,674			1,193,101
Total Assets	$	16,215,801		$	9,916,831
Liabilities and Stockholders’ Equity
Current Liabilities:
Accounts payable and accrued expenses	$	868,000		$	1,449,582
Deferred revenue		205,109			200,109
Other liabilities	-				13,528
Total Current Liabilities		1,073,109			1,663,219
Total Liabilities		1,073,109			1,663,219
Stockholders’ Equity
Preferred stock: 50,000,000 convertible Series D preferred shares authorized; par value $0.0001 per share, nil issued and outstanding at March 31, 2023 and December 31, 2022		—			—
Common stock : 200,000,000 common shares authorized, par value $0.0001 per share, 128,840,421 and 126,702,545 shares outstanding at March 31, 2023 and December 31, 2022, respectively		12,883			12,669
Additional paid-in capital		24,619,639			16,110,221
Accumulated (deficit)		(9,490,325	)		(7,849,982	)
Accumulated other comprehensive loss		495			(19,296	)
Total Stockholders’ Equity		15,142,692			8,253,612
Total Liabilities and Stockholders’ Equity	$	16,215,801		$	9,916,831

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

3

374Water, Inc. and Subsidiaries      

Condensed Consolidated Statements of Operations

For the three months ended March 31, 2023 and 2022

(Unaudited)

	Three months ended March 31,
	2023			2022
Revenue	$	801,458		$	273,231
Cost of goods sold		720,146			247,986
Gross profit		81,312			25,245
Operating Expenses
Research and development		355,905			185,653
Compensation and related expenses		718,760			301,235
Professional fees		99,572			150,658
General and administrative		585,659			261,403
Total Operating Expenses		1,759,896			898,950
Loss from Operations		(1,678,584	)		(873,705	)
Other Income (Expense)
Interest income		37,859			840
Other income		382			7
Total Other Income (Expense)		38,241			847
Net Loss before Income Taxes		(1,640,343	)		(872,858	)
Provision for Income Taxes		—			—
Net Loss	$	(1,640,343	)	$	(872,858	)
Other comprehensive loss
Change in foreign currency translation		824			—
Change in unrealized loss on marketable securities		18,967			—
Total other comprehensive loss		19,791			—
Total comprehensive loss		(1,620,552	)		(872,858	)
Net Loss per Share - Basic and Diluted	$	(0.01	)	$	(0.01	)
Weighted Average Common Shares Outstanding - Basic and Diluted		127,146,695			126,499,142

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

4

374Water Inc. and Subsidiaries      

Condensed Consolidated Changes in Stockholders’ Equity

For the three months ended March 31, 2023 and 2022

(Unaudited)

For the three months ended March 31, 2023

	Preferred Stock				Common Stock				Additional					Other			Total
	Number of				Number of				Paid in		Accumulated			Comprehensive			Stockholders’
	Shares		Amount		Shares		Amount		Capital		Deficit			Income			Equity
Balances, December 31, 2022		—	$	—		126,702,545	$	12,669	$	16,110,221	$	(7,849,982	)	$	(19,296	)	$	8,253,612
Issuance of shares of common stock		—		—		2,137,876		214		8,294,494		—			—			8,294,708
Stock-based compensation		—		—		—		—		214,924		—			—			214,924
Foreign currency gain (Loss)		—		—		—		—		—		—			824			824
Unrealized gain (loss) on investments		—		—		—		—		—		—			18,967			18,967
Net loss		—		—		—		—		—		(1,640,343	)		—			(1,640,343	)
Balances, March 31, 2023		—		—		128,840,421	$	12,883	$	24,619,639	$	(9,490,325	)		495		$	15,142,692

For the three months ended March 31, 2022

	Preferred Stock						Common Stock				Additional						Other		Total
	Number of						Number of				Paid in			Accumulated			Comprehensive		Stockholders’
	Shares			Amount			Shares		Amount		Capital			Deficit			Income		Equity
Balances, December 31, 2021		27,272		$	3			125,317,746	$	12,531	$	15,474,566		$	(3,160,015	)	$	—	$	12,327,085
Conversion of preferred shares to common shares		(27,272	)		(3	)		1,363,149		136		(135	)		—			—		(2	)
Stock-based compensation		—			—			—		—		97,558			—			—		97,558
Net loss		—			—			—		—		—			(872,858	)		—		(872,858	)
Balances, March 31, 2022		—			—			126,680,895	$	12,667	$	15,571,989		$	(4,032,873	)		—	$	11,551,783

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

5

374Water Inc. and Subsidiaries    

Condensed Consolidated Statements of Cash Flows

For the three months ended March 31, 2023 and 2022 (Unaudited)

	2023			2022
Cash Flows from Operating Activities
Net loss	$	(1,640,343	)	$	(872,858	)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization expense		29,105			16,458
Stock based compensation		214,924			97,558
Change in foreign currency translation		824			—
Changes in operating assets and liabilities:
Accounts receivable		(26,188	)		—
Unbilled accounts receivable		(754,290	)		—
Other accounts receivable		(308,374	)		—
Inventory		(127,309	)		—
Prepaid expenses		23,285			(50,599	)
Accounts payable and accrued expenses		(581,582	)		81,059
Deferred revenue		5,000			763,333
Other liabilities		(13,528	)		(20,238	)
Cash Provided by (Used In) Operating Activities		(3,178,476	)		115,911
Cash Flows from Investing Activities
Purchase of equipment		(7,303	)		(3,291	)
Increase in intangible assets		(2,705	)		—
Cash Provided by (Used In) Investing Activities		(10,008	)		(3,291	)
Cash Flow from Financing Activities
Proceeds from the issuance of common stock		8,294,708			—
Cash Provided by Financing Activities		8,294,708			—
Net Increase in Cash		5,106,224			112,620
Cash, Beginning of the Period		4,046,937			11,131,175
Cash, End of the Period	$	9,153,161		$	11,243,795
NON-CASH FINANCING ACTIVITIES
Conversion of preferred stock to common stock	$	—		$	133

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

6

374Water Inc. and Subsidiaries

Notes to Unaudited Condensed Consolidated Financial Statements

Note 1 – Nature of Business and Presentation of Financial Statements

Description of the Company

374Water Inc. (the “Company”, “374Water”, “We”, or “Our”) is a Delaware corporation which was formed in September 2005 as PowerVerde, Inc. At that time, the Company was focused on developing, commercializing and marketing a series of unique electric generating power systems designed to produce electrical power with zero emissions or waste byproducts, based on a pressure-driven expander motor and related organic rankine cycle technology.

On April 16, 2021, the Company entered into an Agreement and Plan of Merger (the “Merger”) with 374Water Inc., a privately held company based in Durham, North Carolina, (“374Water Private Company”) and 374Water Acquisition Corp., a newly-formed wholly-owned subsidiary of PowerVerde.

Following the Merger, 374Water offers a disruptive technology that transforms all wet wastes such as sewage sludge, biosolids, food waste, hazardous and non-hazardous waste, and forever chemicals (e.g., PFAS) into recoverable resources by focusing on waste as a valuable resource for water, energy, and minerals. We are pioneers in a new era of waste management that supports a circular economy and enables organizations to achieve their environment, social, and governance (ESG) goals. Our vision is a world without waste and our mission is to help create and preserve a clean and healthy environment that sustains life.

Presentation of Financial Statements

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America and the rules and regulations of the United States Securities and Exchange Commission (the “SEC”) for interim financial information. It is management’s opinion that the accompanying unaudited condensed consolidated financial statements are prepared in accordance with instructions for Form 10-Q and include all adjustments (consisting only of normal recurring accruals) which are necessary for a fair presentation of the results for the periods presented. Certain information and footnote disclosures normally included in the consolidated financial statements prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") have been condensed or omitted. It is suggested that these condensed consolidated financial statements be read in conjunction with the Annual Report on Form 10-K of 374Water Inc. (“374 Water," “we,” “us,” “our,” or the “Company”) as of and for the year ended December 31, 2022 filed with the Securities and Exchange Commission (“SEC”) on March 16, 2023.

The results of operations for the three months ended March 31, 2023, are not necessarily indicative of the results to be expected for the full year or for future periods. The condensed consolidated financial statements include the accounts of 374Water Inc., 374Water Systems Inc, and 374Water Sustainability Israel LTD, each a wholly-owned subsidiary of 374 Water. Intercompany balances and transactions have been eliminated in consolidation.

7

Note 2 – Summary of Significant Accounting Policies

Cash and Cash Equivalents and Marketable Securities

The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents. The Company held $2,696,107 and $1,182,412 in cash equivalents as of March 31, 2023 and December 31, 2022, respectively.

The Company held marketable securities as of March 31, 2023 as noted in the following table:

	Adjusted Cost		Unrealized Losses		Fair Value		Cash and Cash Equivalents		Current Marketable Securities		Non-Current Marketable Securities
Cash	$	9,153,161		—	$	9,153,161	$	9,153,161		—		—
Level 2:
U.S. Treasury securities	$	1,960,761	$	8,049	$	1,952,712	$	—	$	1,952,712		—
Total	$	11,113,922	$	8,049	$	11,105,873	$	9,153,161	$	1,952,712		—

The Company held marketable securities as of December 31, 2022 as noted in the following table:

	Adjusted Cost		Unrealized Losses		Fair Value		Cash and Cash Equivalents		Current Marketable Securities		Non-Current Marketable Securities
Cash	$	4,046,937		—	$	4,046,937	$	4,046,937		—		—
Level 2:
U.S. Treasury securities	$	1,963,432	$	18,968	$	1,944,464	$	—	$	1,944,464		—
Total	$	6,010,369	$	18,968	$	5,991,401	$	4,046,937	$	1,944,464		—

Accounting Standards Codification (ASC) Topic 820 “Fair Value Measurements” establishes a fair value hierarchy that prioritizes the information used to develop those assumptions. The fair value hierarchy is as follows:

Level 1 Inputs - Unadjusted quoted prices in active markets for identical assets or liabilities that the entity has the ability to access at the measurement date.

Level 2 Inputs - Fair value estimates are based on observable inputs other than quoted prices in active markets for identical assets and liabilities, quoted prices for identical or similar assets or liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

Level 3 Inputs - Unobservable inputs for determining the fair values of assets or liabilities that reflect an entity’s own assumptions about the assumptions that market participants would use in pricing the assets or liabilities.

The following is a description of valuation methodologies used for assets and liabilities recorded at an amortized cost basis:

∙ Investment Securities Held-to-Maturity. Investment securities held-to-maturity (“HTM”) are recorded at their initial cost, and any discount or premium amortized over the remaining life of the security. The carrying value of the investment is adjusted for the amortized amount of any discount or premium at each reporting period.

8

Accounts Receivable

Accounts receivables consist of balances due from service revenues, unbilled accounts receivables which is for revenues earned but not yet billed, and other receivables relating to common stock subscription purchases where the stock has been transferred but the cash has not been received. The Company monitors accounts receivable and provides allowances when considered necessary. At March 31, 2023 and December 31, 2022, accounts receivable were considered to be fully collectible but in accordance with the allowance for credit losses, the Company recorded an allowance for bad debt based on a reserve of current and aged receivables. Accordingly, an allowance for doubtful accounts of $191 and $0 was recorded as of March 31, 2023 and December 31, 2022, respectively. 

Accounts Receivable

Accounts receivables consist of balances due from sales and service revenues and accrued interest from the investment account. 

Unbilled Accounts Receivable

Unbilled accounts receivables consist of balances due from sales and service revenue earned but not yet billed. 

Other Accounts Receivable

Other accounts receivables consist of cash due from the investment bank after the sale of common stock that has not cleared the bank yet by the end of the period.  The cash is transferred from the investment bank to the Company typically within 3 to 5 days of the sale of common stock. 

Accounts receivable allowance for credit losses

The activity related to the accounts receivable allowance for credit losses was as follows:

Name	Three Months Ending at March 31, 2023		Three Months Ending at March 31, 2022
Beginning balance	$	—	$	—
Current period provision		191		—
Write-offs		—		—
Ending Balance	$	191	$	—

Inventories

Inventories are stated at the lower of cost or net realizable value. Cost is determined on a first-in, first-out basis. The majority of our inventory is raw materials and work in progress.  Net realizable value is the value of an asset that can be realized upon the sale of the asset, less a reasonable estimate of the costs associated with either the eventual sale or the disposal of the asset in question.  We utilize third-party suppliers to produce our products. Costs associated with fabrication, and other costs associated with the manufacturing of products, are recorded as inventory. We periodically evaluate the carrying value of our inventories in relation to estimated forecasts of product demand, which takes into consideration the life cycle of product releases. When quantities on hand exceed estimated sales forecasts, we perform an analysis to determine if a write-down for such excess inventories is required.  Once inventory has been written down, it creates a new cost basis for inventory.  Inventories are classified as current assets in accordance with recognized industry practice.

9

Property and Equipment

Property and Equipment is recorded at cost. Depreciation is computed using the straight-line method and an estimated useful life of three years. Expenses for maintenance and repairs are charged to expense as incurred.  Depreciation expense related to property and equipment was as follows:

	Period Ended March 31,
	2023		2022
Depreciation	$	9,525	$	235

Intangible Assets

Intangible assets are subject to amortization, and any impairment is determined in accordance with ASC 360, “Property, Plant, and Equipment.” Intangible assets are stated at historical cost and amortized over their estimated useful lives. The Company uses a straight-line method of amortization unless a method that better reflects the pattern in which the economic benefits of the intangible asset are consumed or otherwise used up can be reliably determined. As of March 31, 2023 and December 31, 2022, there was no impairment.

Long-Lived Assets

The Company reviews long-lived assets, including intangible assets with finite lives, for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The Company uses an estimate of the undiscounted cash flows over the remaining life of its long-lived assets, or related group of assets where applicable, in measuring whether the assets to be held and used will be realizable. Recoverability of assets held and used is measured by a comparison of the carrying amount to the future undiscounted expected net cash flows to be generated by the asset. As of March 31, 2023 and December 31, 2022, there were no impairments.

Concentrations of Credit Risk

Financial instruments that potentially subject the Company to credit risk consist of cash and cash equivalents, and marketable securities. Deposits with financial institutions are insured, up to certain limits, by the Federal Deposit Insurance Corporation (“FDIC”). The Company’s cash deposits often exceed the FDIC insurance limit; however, all deposits are maintained with high credit quality institutions and the Company has not experienced any losses in such accounts. The financial condition of financial institutions is periodically reassessed, and the Company believes the risk of any loss is minimal. The Company believes the risk of any loss on cash due to credit risk is minimal. Furthermore, we perform ongoing credit evaluations of our customers and generally do not require collateral.

Significant customers and suppliers are those that account for greater than 10% of the Company’s revenues and purchases.  Our customer revenue for one customer made up over 90% of revenue for the period ended March 31, 2023 and year ended December 31, 2022. In 2023 and 2022, the Company purchased a substantial portion of manufacturing services from one third party vendor, Merrell Bros Fabrication, LLC.

Revenue Recognition

The Company follows the revenue standards of Codification (ASC) Topic 606: “Revenue from Contracts with Customers (Topic 606).” The core principle of this Topic is that an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Revenue is recognized in accordance with that core principle by applying the following five steps: 1) identify the contracts with a customer; 2) identify the performance obligations in the contract; 3) determine the transaction price; 4) allocate the transaction price to the performance obligations; and 5) recognize revenue when (or as) we satisfy a performance obligation using the input method.

10

The Company’s performance obligations are satisfied over time over the life of the contract. The Company's revenue arrangements consist of a single performance obligation to transfer services. Revenue is recognized over time by measuring the progress toward complete satisfaction of the performance obligation using specific milestones. These milestones within the contract are assigned revenue recognition percentages, based on overall expected cost-plus margin estimates of those milestones compared to the total cost of the contract. Contract revenues are recognized in the proportion that contract costs incurred bear to total estimated costs. This method is used because management considers the input method to be the best available measure of progress on these contracts. Contract costs include all direct material and labor and subcontractor costs and those indirect costs related to contract performance, such as indirect labor, supplies, tools, repairs, and depreciation. General, selling, and administrative costs are charged to expense as incurred.

We also record as revenue all amounts billed to customers for shipping and handling costs and record the actual shipping costs as a component of cost of revenues. Reimbursements received from customers for out-of-pocket expenses are recorded as revenues, with related costs recorded as cost of revenues. We present revenues net of any taxes collected from customers and remitted to government authorities.

Revenues for the period ended March 31, 2023 in the amount of $793,458 was generated from the sale of the AirSCWO system and $8,000 was generated from the sale of treatability services. 

Revenues for the year ended December 31, 2022 in the amount of $2,952,020 was generated from the sale of the AirSCWO system and $63,501 was generated from the sale of treatability services. 

Stock-based Compensation

The Company has accounted for stock-based compensation under the provisions of ASC Topic 718 – “Stock Compensation” which requires the use of the fair-value based method to determine compensation for all arrangements under which employees and others receive shares of stock or equity instruments (stock options and common stock purchase warrants). The fair value of each stock option award is estimated on the date of grant using the Black-Scholes valuation model that uses assumptions for expected volatility, expected dividends, expected term, and the risk-free interest rate. Expected volatilities are based on historical volatility of peer companies and other factors estimated over the expected term of the stock options. The expected term of options granted is derived using the “simplified method” which computes expected term as the average of the sum of the vesting term plus the contract term. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for the period of the expected term.

Income Tax Policy

The Company accounts for income taxes using the liability method prescribed by ASC 740 - Income Taxes. Under this method, deferred tax assets and liabilities are determined based on the difference between the financial reporting and tax bases of assets and liabilities using enacted tax rates that will be in effect in the year in which the differences are expected to reverse. The Company records a valuation allowance to offset deferred tax assets if, based on the weight of available evidence, it is more-likely-than-not that some portion, or all, of the deferred tax assets will not be realized. The effect on deferred taxes of a change in tax rates is recognized as income or loss in the period that includes the enactment date.

Accounting for Uncertainty in Income Taxes

The Company follows the provisions of ASC Topic 740-10, “Accounting for Uncertainty in Income Taxes” which clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. This topic also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition. There were no uncertain tax positions as of March 31, 2023 and December 31, 2022.

11

Research and Development Costs

The Company’s research and development costs are expensed in the period in which they are incurred. Such expenditures amounted to $355,905 and $185,653 for the three months ended March 31, 2023, and 2022, respectively.

Earnings (Loss) Per Share

Earnings (loss) per share is computed in accordance with ASC Topic 260, “Earnings per Share” Basic weighted-average number of shares of common stock outstanding for the years ended March 31, 2023 and December 31, 2022 include the shares of the Company issued and outstanding during such periods, each on a weighted average basis. The basic weighted average number of shares common stock outstanding excludes common stock equivalent incremental shares, while diluted weighted average number of shares outstanding includes such incremental shares. However, as the Company was in a loss position for all periods presented, basic and diluted weighted average shares outstanding are the same, as the inclusion of the incremental shares would be anti-dilutive.  As of March 31, 2023 and December 31, 2022, there were the following potentially dilutive securities that were excluded from diluted net loss per share because their effect would be antidilutive: options for 13,025,000 shares of common stock and 1,250,000 warrants. 

Financial Instruments

The Company carries cash, accounts receivable, accounts payable and accrued expenses, at historical costs. The respective estimated fair values of these assets and liabilities approximate carrying values / useful lives of equipment and intangible assets due to their current nature.

12

Foreign Currency Translation

All assets and liabilities of the Companies’ locations whose accounts are denominated in foreign currency are translated into United States dollars at appropriate year-end current exchange rates.  All income and expense accounts of those locations are translated at the average exchange rate for each period.  The foreign currency translation amounts for the period ended March 31, 2023 and the year ended December 31, 2022 are included in accumulated comprehensive income on the consolidated statement of changes in equity.

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates in the accompanying financial statements include the fair value of equity-based compensation, revenue, fair value of intangible assets, useful lives of intangible assets, capital raise transactions, and valuation allowance against deferred tax assets.

Recent Accounting Pronouncements

In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which amends guidance on reporting credit losses for assets held at amortized cost basis and available for sale debt securities.  For assets held at amortized cost basis, Topic 326 eliminates the probable initial recognition threshold in current GAAP and, instead, requires an entity to reflect its current estimate of all expected credit losses.  The allowance for credit losses is a valuation account that is deducted from the amortized cost basis of the financial assets to present the net amount expected to be collected.  For available for sale debt securities, credit losses should be measured in a manner similar to current GAAP, however Topic 326 will require that credit losses be presented as an allowance rather than as a write-down.  This ASU affects entities holding financial assets and net investment in leases that are not accounted for at fair value through net income. The amendments affect loans, debt securities, trade receivables, net investments in leases, off balance sheet credit exposures, reinsurance receivables, and any other financial assets not excluded from the scope that have the contractual right to receive cash. The amendments in this update are effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years.  The Company has completed its assessment on the impact of the adoption of the ASU on its financial statements, disclosure requirements and methods of adoption and noted that there is no impact at this time for our HTM investments and noted a small adjustment for the allowance for bad debt which has been recorded as of March 31, 2023. 

The Company considers the applicability and impact of all recently issued accounting pronouncements. Recent accounting pronouncements not specifically identified in our disclosures are either not applicable to the Company or are not expected to have a material effect on our financial condition or results of operations.

Note 3 – Liquidity, Capital Resources and Going Concern

As of March 31, 2023, the Company had working capital of $13,966,018 compared to working capital of $7,060,511 at December 31, 2022.  As of March 31, 2023, the Company had an accumulated deficit of $9,490,325. For the three months ended March 31, 2023, the Company had a net loss of $1,640,343 and used $3,178,476 of net cash in operations for the period.

The Company believes it has sufficient cash-on-hand (including its marketable securities described in Note 2 above) for the Company to meet its financial obligations as they come due at least the next 12 months from the date of the report. 

Note 4 – Inventory

Inventory consists of:

Name	Balance at March 31, 2023		Balance at December 31, 2022
Raw materials	$	533,925	$	755,218
Work-in-process		1,254,094		905,492
Total	$	1,788,019	$	1,660,710

As of March 31, 2023 and December 31, 2022, the Company noted no inventory impairment and there were no inventory write downs recorded. 

13

Note 5 – Intangible Assets

Intangible assets are recorded at cost and consist of the License Agreement with Duke University. The Company issued Duke University a small number of shares of common stock estimated to have a fair value of $1,073,529 as consideration for granting the Company the license based on the Company’s common stock market price on the date the License Agreement was executed (see Note 9). Intangible assets are comprised of the following as of March 31, 2023 and December 31, 2022:

Name	Estimated Life	Balance at December 31, 2022		Additions		Amortization		Balance at March 31, 2023
License agreement	17 Years	$	964,965	$	—	$	15,787	$	949,178
Patents	20 Years		85,057		2,705		1,123		86,639
Total		$	1,050,022	$	2,705	$	16,910	$	1,035,817

Name	Estimated Life	Balance at December 31, 2021		Additions		Amortization		Balance at December 31, 2022
License agreement	17 Years	$	1,028,114	$	-	$	63,149	$	964,965
Patents	20 Years		34,742		52,292		1,977		85,057
Total		$	1,062,856	$	52,292	$	65,126	$	1,050,022

Amortization expense for the three months ended March 31, 2023 and 2022, was $16,910 and $16,458, respectively.

14

Estimated future amortization expense as of March 31, 2023:

	March 31,
	2023
2023	$	50,827
2024		67,769
2025		67,769
2026		67,769
2027		67,769
Thereafter		713,914
Intangible assets, Net	$	1,035,817

Note 6 – Revenue 

The following is a summary of our revenues by type for the period ended March 31, 2023 and March 31, 2022:

Name	Balance at March 31, 2023		%			Balance at March 31, 2022		%
Equipment revenue	$	793,458		99	%	$	273,231		100	%
Service revenue		8,000		1	%		—		—	%
Total	$	801,458		100	%	$	273,231		100	%

15

Unearned Revenue

The following is a summary of our unearned revenue activity for the period ended March 31, 2023 and year ended December 31, 2022: 

Name	Balance at March 31, 2023		Balance at December 31, 2022
Unearned revenue at beginning of year	$	200,109	$	—
Billings deferred		5,000		1,467,189
Recognition of prior unearned revenue		—		(1,267,080	)
Unearned revenue at end of year	$	205,109	$	200,109

Unbilled Accounts Receivable

The following is a summary of our unbilled accounts receivable activity for the period ended March 31, 2023 and the year ended December 31, 2022:

Name	Balance at March 31, 2023			Balance at December 31, 2022
Unbilled accounts receivable at beginning of year	$	918,164		$	—
Services performed but unbilled		793,458			918,164
Services billed		(39,168	)		—
Unbilled accounts receivable at end of year	$	1,672,454		$	918,164

Note 7 – Stockholder’ Equity

The Company is authorized to issue 50,000,000 preferred stock shares and 200,000,000 common stock shares both with a par value of $0.0001.

Preferred Stock

On October 30, 2020, the Company designated 1,000,000 shares as Series D Convertible Preferred Stock with a par value of $0.0001.

On April 16, 2021, the Company closed on a private placement of 440,125 shares of Series D Convertible Preferred Stock (the “Preferred Stock'') with a par value of $0.0001, yielding gross proceeds of $6,551,691 (the “Private Placement”) and settlement of a $50,000 liability for Preferred Stock shares. The Private Placement proceeds will be used for working capital, primarily for the development, manufacturing and commercialization of 374Water’s Air SCWO systems. The Preferred Stock has a stated value of $15 per share, is convertible into common stock at $0.30 per share and has voting rights based on the underlying shares of common stock. Upon liquidation of the Company, the Preferred Stockholders have a liquidation preference before any assets can be distributed to common stockholders. All of the Preferred Stock were sold pursuant to an exemption from registration requirements under Regulation D and/or Section 4(2) of the Securities Act of 1933, as amended. On September 29, 2021, 412,853 shares of Preferred Stock were converted into 20,642,667 shares of common stock.  On January 12, 2022, the Company converted the remaining 27,272 shares of Preferred Stock to 1,363,149 shares of common stock.  As of March 31, 2023, there were no shares of Preferred Stock issued and outstanding.

Common Stock

The holders of common stock are entitled to one vote per share on all matters submitted to a vote of shareholders, including the directors’ election. There is no right to cumulative voting in the election of directors. The holders of common stock are entitled to any dividends that may be declared by the board of directors out of funds legally available for payment of dividends subject to the prior rights of holders of preferred stock and any contractual restrictions the Company has against the payment of dividends on common stock. In the event of our liquidation or dissolution, holders of common stock are entitled to share ratably in all assets remaining after payment of liabilities and the liquidation preferences of any outstanding shares of preferred stock. Holders of common stock have no preemptive rights and have no right to convert their common stock into any other securities. As of March 31, 2023, there were 128,840,421 shares of common stock issued and outstanding.

16

In December 2022, the Company entered into an equity distribution agreement with an underwriter pursuant to which the Company may offer and sell shares of its common stock from time to time through the underwriter as its sales agent. Sales of common stock, if any, will be made at market prices by any method permitted by law deemed to be an “at-the-market” offering as defined in Rule 415 promulgated under the Securities Act of 1933, as amended. The Company has no obligation to sell any shares of common stock under the equity distribution agreement, and may at any time suspend offers under the equity distribution agreement, in whole or in part, or terminate the equity distribution agreement.

During the three months ended March 31, 2023, a total of 2,137,876 shares of common stock have been sold pursuant to the equity distribution agreement resulting in a total of $8.35 million in proceeds, net of $0.11 million of commission fees and $0.05 million of accounting and legal fees. As of March 31, 2023, $91.5 million remained available under the Company’s at-the-market public facility, subject to various limitations.

Stock-based compensation

During the three months ended March 31, 2023, and 2022, the Company recorded stock-based compensation of $214,924 and $97,558, respectively, related to common stock issued or vested options to employees and various consultants of the Company. For the three months ended March 31, 2023, $189,283 was charged as general and administrative expenses and $25,641 as research and development expenses in the accompanying condensed consolidated statements of operations.  For the three months ended March 31, 2022, $93,868 was charged as general and administrative expenses and $3,690 as research and development expenses in the accompanying condensed consolidated statements of operations.

Stock Options

Stock option activity for the three months ended March 31, 2023 is summarized as follows:

	Shares		Weighted Average Exercise Price		Aggregate Intrinsic Value		Weighted Average Remaining Contractual Life (Years)
Options outstanding at December 31, 2022		12,752,000	$	0.62	$	28,543,370		5.09
Granted		273,000		3.09		—		—
Exercised		—		—		—		—
Expired/forfeit		—		—		—		—
Options outstanding at March 31, 2023		13,025,000		0.67	$	52,705,860		4.93

Stock option activity for the three months ended March 31, 2022 is summarized as follows:

	Shares		Weighted Average Exercise Price		Aggregate Intrinsic Value		Weighted Average Remaining Contractual Life (Years)
Options outstanding at December 31, 2021		12,300,000	$	0.37	$	30,504,000		5.62
Granted		360,000		3.33		—		—
Exercised		—		—		—		—
Expired/forfeit		—		—		—		—
Options outstanding at March 31, 2022		12,660,000		0.45	$	45,576,000		5.39

Total unrecognized compensation associated with these unvested options is approximately $2,213,723 which will be recognized over a period of four years.

17

The fair value of these options granted were estimated on the date of grant, using the Black-Scholes option-pricing model with the following assumptions:

	March 31, 2023			March 31, 2022
Dividend yield		0.00	%		0.00	%
Expected life	5.45 – 5.79 Years			5.65 – 5.75 Years
Expected volatility	35.24 – 35.88		%	37.73 – 39.18		%
Risk-free interest rate	3.58 – 3.97		%	1.44 – 2.12		%

Stock Warrants

As of March 31, 2023, there were 1,250,000 warrants outstanding which relate to the Series 1 offering executed in December 2021, where investors were offered a warrant for every two common shares purchased during the offering at an exercise price of $2.50 per share. The intrinsic value of all outstanding warrants as of March 31, 2023 was $2,775,000 based on the market price of our common stock of $4.72 per share, which was the Company’s closing per share common stock price as reported on Nasdaq as of March 31, 2023.

During the three months ended March 31, 2023, no warrants were issued or exercised. As of March 31, 2023, there are 1,250,000 outstanding warrants. 

 A summary of warrant activity during the three months ended March 31, 2023, is as follows:

	Shares		Weighted Average Exercise Price		Aggregate Intrinsic Value		Weighted Average Remaining Contractual Life (Years)
Balance at December 31, 2022		1,250,000		2.50	$	450,000		1.96
Issued		—		—		—		—
Exercised		—		—		—		—
Balance at March 31, 2023		1,250,000		2.50	$	2,775,000		1.72

Note 8 - Related Party Transactions

In 2021, the Company entered into an agreement to fabricate and manufacture the AirSCWO systems with Merrell Bros. Holding Company. As part of the agreement, the Company appointed Terry Merrell to its board of directors. As of March 31, 2023, Merrell Bros. or their affiliates own stock in excess of 5% of the outstanding common stock.  As of March 31, 2023, the Company incurred $535,201 in related party expenses, of which $514,399 was related to the manufacturing of the AirSCWO systems. As of March 31, 2023, there is an accrual of $446,081 in related party expenses, of which $432,582 related to the manufacturing of the AirSCWO systems.

Note 9 - Commitments

The patented technology underlying 374Water’s supercritical water oxidation (SCWO) units, which was developed principally through the efforts of Messrs. Nagar and Deshusses at the facilities of Duke University, Durham, North Carolina (“Duke”), where Dr. Deshusses is a professor. The SCWO technology is licensed to 374Water pursuant to a worldwide license agreement with Duke executed on April 16, 2021 (the “License Agreement”). In connection with the License Agreement, 374Water also executed an equity transfer Agreement with Duke pursuant to which Duke received a small number of common stock in the Company (See Notes 5 and 7). Under the terms of the License Agreement, the Company is required to make royalty payments based on a percentage of licensed product sales, as defined in the License Agreement which is triggered by the sale of licensed products. Further, the Company is also required to pay royalties on a percentage of sublicensing fees. The Company will reimburse Duke for any ongoing patent expenses incurred. During the three-month period ending March 31, 2023, the Company has not incurred any expenses in connection with this License Agreement. The Company may terminate the license agreement anytime by providing Duke 60 days’ written notice.

Note 10 - Subsequent Events

From April 1, 2023 through May 5, 2023, we raised approximately $717,835 in net proceeds through an at-the-market equity offering of 152,285 shares of common stock.  Pursuant to the at-the-market equity offering, we may issue up to $100 million of common stock, less the amounts already raised.

18

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Forward Looking Statements

Readers are cautioned that the statements in this Report that are not descriptions of historical facts may be “forward-looking statements” that are subject to risks and uncertainties. This Report contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements are based on the beliefs of our management, as well as on assumptions made by and information currently available to us as of the date of this Report. When used in this Report, the words “plan,” “will,” “may,” “anticipate,” “believe,” “estimate,” “expect,” “intend,” “project” and similar expressions are intended to identify such forward-looking statements. Although we believe these statements are reasonable, actual actions, operations and results could differ materially from those indicated by such forward-looking statements as a result of the risk factors included in our 2022 Annual Report on Form 10-K filed with the SEC on March 16, 2023, or other factors. We must caution, however, that this list of factors may not be exhaustive and that these or other factors, many of which are outside of our control, could have a material adverse effect on us and our ability to achieve our objectives. All forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by the cautionary statements set forth above.

The following discussion and analysis should be read in conjunction with the financial statements and notes thereto appearing elsewhere herein.

Critical Accounting Policies

The condensed consolidated financial statements of the Company are prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”). The preparation of these condensed consolidated financial statements requires our management to make estimates and assumptions about future events that affect the amounts reported in the financial statements and related notes. Future events and their effects cannot be determined with absolute certainty. Therefore, the determination of estimates requires the exercise of judgment. We believe the following critical accounting policies affect its more significant judgments and estimates used in the preparation of financial statements.

Accounting for Uncertainty in Income Taxes

The Company follows the provisions of ASC Topic 740-10, “Accounting for Uncertainty in Income Taxes” which clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. This topic also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition.

Based on our evaluation, we have concluded that there are no significant uncertain tax positions requiring recognition in our condensed consolidated financial statements. Our evaluation was performed for the tax years ended December 31, 2020, 2021, and 2022 the tax years which remain subject to examination by major tax jurisdictions as of March 31, 2023.

We may from time to time be assessed interest or penalties by major tax jurisdictions, although any such assessments historically have been minimal and immaterial to our financial results. In the event we have received an assessment for interest and/or penalties, it has been classified in the condensed consolidated financial statements as general and administrative expense.

19

Revenue Recognition

Revenues for the three months ended March 31, 2023 were generated from the sale of an AirSCWO system, and consulting and advisory services, which were recognized when the Company performed the service pursuant to its agreements with its clients which was the point in time when the Company completed its performance obligations under the agreements.

Common Stock Purchase Warrants

The Company accounts for common stock purchase warrants in accordance with ASC Topic 815- 40, Derivatives and Hedging – Contracts in Entity’s Own Equity (“ASC 815-40”). Based on the provisions of ASC 815- 40, the Company classifies as equity any contracts that (i) require physical settlement or net-share settlement, or (ii) gives the Company a choice of net-cash settlement or settlement in its own shares (physical settlement or net-share settlement). The Company classifies as assets or liabilities any contracts that (i) require net-cash settlement including a requirement to net cash settle the contract if an event occurs and if that event is outside the control of the Company), or (ii) give the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement). As of March 31, 2023, there were 1,250,000 outstanding warrants classified as equity.

Stock-based compensation.

We account for stock-based compensation based on ASC Topic 718-Stock Compensation which requires expensing of stock options and other share-based payments based on the fair value of each stock option awarded. The fair value of each stock option is estimated on the date of grant using the Black-Scholes valuation model. This model requires management to estimate the expected volatility, expected dividends, and expected term as inputs to the valuation model.

Overview

374Water offers a technology that transforms wet wastes such as sewage sludge, biosolids, food waste, hazardous and non-hazardous waste, and forever chemicals (e.g., PFAS) into recoverable resources by focusing on waste as a valuable resource for water, energy, and minerals. We consider ourselves pioneers in a new era of waste management that supports a circular economy and enables organizations to achieve their environment, social, and governance (ESG) goals. Our vision is a world without waste and our mission is to help create and preserve a clean and healthy environment that sustains life.

We have developed proprietary waste stream treatment systems based on Supercritical Water Oxidation (SCWO). The term used for the process is AirSCWO^TM. SCWO leverages the unique properties of water in its supercritical phase (above 374 ^oC and 221 Bar) to convert organic matter to energy and safe products that can be recovered and used. The AirSCWO^TM systems are essentially waste stream agnostic and able to treat a variety of complex, hazardous and non-hazardous waste streams, opening up opportunities for multiple applications in diverse market verticals on an international scale. Most pertinently, the technology is shifting the landscape in addressing environmental challenges that, until now, have been considered unsurmountable (due to science/engineering or cost barriers), one good example being the global PFAS crisis.

We currently outsource manufacturing of the AirSCWO^TM systems to our strategic partner in the US, Merrell Bros., Inc., that have the facilities and capability to rapidly ramp-up manufacturing volumes and also support system modifications and deployment as required per market and clients. We envision in the future applying an outsourced manufacturing model in a few territories, and may consider establishing our own manufacturing capability in geographies where this is needed to adequately grow our market share.

 The systems are supplied to multiple market verticals, and our revenue model includes both capital equipment sales and long-term service agreements based on throughput and capacity (Waste Purchase Agreements). Our market penetration strategy is combined of direct client and channel partner sales routes, depending on the specific market and territory. In some cases, the systems may be white labeled and sold as part of a broader solution package.

20

Results of Operations

The following table sets forth, for the periods presented, the consolidated statements of operations data, which is derived from the accompanying consolidated financial statements: 

	Period Ended March 31,
	2023			2022			$ Change			% Change
Revenue	$	801,458		$	273,231		$	528,227			193	%
Cost of revenues		720,146			247,986			472,160			190	%
Net revenue		81,312			25,245			56,067			222	%
Operating expenses:
Research and development		355,905			185,653			170,252			92	%
Compensation and related expenses		718,760			301,235			417,525			139	%
Professional fees		99,572			150,658			(51,086	)		(34	%)
General and administrative		585,659			261,403			324,256			124	%
Total operating expenses		1,759,896			898,950			860,946			96	%
Income (loss) from operations		(1,678,584	)		(873,705	)		(804,879	)		92	%
Other income (expenses), net		38,241			847			37,394			4,415	%
Income (loss) before income taxes		(1,640,343	)		(872,858	)		(767,485	)		88	%
Provision for (benefit from) income taxes		—			—			—			0	%
Net income (loss)	$	(1,640,343	)	$	(872,858	)	$	(767,485	)		88	%

Three Months Ended March 31, 2023, as Compared to the Three Months Ended March 31, 2022

Our business has been focused on development and commercialization of 374Water’s supercritical water oxidation (SCWO) systems. We generated $801,458 and $273,231 in revenue from manufacturing assembly services and from consulting and advisory services during the three months ending March 31, 2023 and March 31, 2022, respectively.

Our general and administrative expenses increased to $585,659 during the three months ending March 31, 2023, as compared to $261,403 in the same period of 2022, primarily because of increased insurance costs and NASDAQ public company expenses. 

Our compensation and related expenses increased to $718,760 during the three months ending March 31, 2023, as compared to $301,235 in the same period of 2022, primarily because of increased payroll and fringe benefit expenses produced by an increase in the Company’s employee headcount. 

Our professional fees slightly decreased to $99,572 during the three months ending March 31, 2023, as compared to $150,658 in the same period of 2022, primarily because of increased legal fees as a result of hiring in house legal counsel.

Our research and development expenses increased to $355,905 during the three months ending March 31, 2023, as compared to $185,653 in the same period of 2022, primarily because of the increase in engineering expenses and our continued efforts to commercialize our systems.

21

Liquidity and Capital Resources

We have an at-the-market equity offering under which we may issue up to $100 million of common stock, which is currently effective and under which we commenced selling shares at the end of January 2023, and which will remain available to us in the future.

We have financed our operations since inception principally through the sale of equity securities and sales of product and services. As of March 31, 2023 we had working capital of $13,966,018 compared to working capital of $7,060,511 at December 31, 2022. This increase in working capital is due primarily to the At the Market common stock offering that raised additional capital. 

We believe that these funds will satisfy our working capital needs for the next 12 months. There can be no assurance that these funds will be sufficient to finance our plan of operations and commercialize our systems or that we will be able to raise any necessary additional funds on a commercially reasonable basis or at all. 

Item 3. Quantitative and Qualitative Disclosures about Market Risk.

Not applicable.

Item 4. Controls and Procedures.

Disclosure Controls and Procedures

The Company, under the supervision and with the participation of its management, including the Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of the design and operation of the Company’s “disclosure controls and procedures” (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of the end of the period covered by this report. Based on that evaluation, the Chief Executive Officer and the Chief Financial Officer concluded that the Company’s disclosure controls and procedures were effective.

Management’s Annual Report on Internal Control Over Financial Reporting

Our management, including our principal executive officer and principal financial officer, is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act).

Our management, with the participation of our principal executive officer and principal financial officer, evaluated the effectiveness of our internal control over financial reporting as of March 31, 2023. Our management’s evaluation of our internal control over financial reporting was based on the framework in Internal Control-Integrated Framework (2013), issued by the Committee of Sponsoring Organizations of the Treadway Commission. Based on this evaluation, our management identified a material weakness relating to the lack of proper detailed review as of March 31, 2023. As a result of this material weakness, our management concluded that our internal control over financial reporting was not effective as of March 31, 2023.

No Attestation Report

This quarterly report does not include an attestation report of the Company’s independent registered public accounting firm regarding internal control over financial reporting. Management’s report was not subject to attestation by the Company’s registered public accounting firm pursuant to rules of the Securities and Exchange Commission that permit the Company to provide only management’s report in this quarterly report.

Changes in Internal Control Over Financial Reporting

Except for controls implemented to address the deficiencies described above, there have been no other changes in our internal control over financial reporting during the first three months of 2023 that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

22

PART II OTHER INFORMATION

Item 1. Legal Proceedings.

None.

Item 1A. Risk Factors.

Not applicable.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

None

Item 3. Defaults Upon Senior Securities.

None.

Item 4. Mine Safety Disclosures.

Not applicable.

Item 5. Other Information.

Not applicable

23

Item 6. Exhibits.

(a) Exhibits

31.1	Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2	Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1	Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2	Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS	XBRL INSTANCE DOCUMENT
101.SCH	XBRL TAXONOMY EXTENSION SCHEMA
101.CAL	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
101.DEF	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
101.LAB	XBRL TAXONOMY EXTENSION LABEL LINKBASE
101.PRE	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE

24

SIGNATURES

In accordance with Section 13(a) or 15(d) of the Exchange Act, the Registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.

	374WATER INC
Dated: May 8, 2023	By:	/s/ Yaacov Nagar
		Yaacov Nagar
		Chief Executive Officer
Dated: May 8, 2023	By:	/s/ Israel Abitbol
		Israel Abitbol
		Chief Financial Officer

25

Exhibit Index

31.1	Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2	Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1	Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2	Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS	XBRL INSTANCE DOCUMENT
101.SCH	XBRL TAXONOMY EXTENSION SCHEMA
101.CAL	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
101.DEF	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
101.LAB	XBRL TAXONOMY EXTENSION LABEL LINKBASE
101.PRE	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE

26

EX-31.1

EXHIBIT 31.1

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

RULE 13a-14(a)/15d-14(a) CERTIFICATIONS

I, Yaacov Nagar, certify that:

1.	I have reviewed this Amendment No. 1 to Form 10-Q/A of 374Water Inc. for the quarterly period ending March 31, 2023;
2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;
3.	Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;
4.	The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal controls over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)	designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;
b)	designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)	evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;
d)	disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting;

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent function):

a)	all significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b)	any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.

Date: May 8, 2023
By:	/s/ Yaacov Nagar
	Chief Executive Officer
	(Principal Executive Officer)

EX-31.2

EXHIBIT 31.2

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER

RULE 13a-14(a)/15d-14(a) CERTIFICATIONS

I, Israel Abitbol, certify that:

1.	I have reviewed this Amendment No. 1 to Form 10-Q/A of 374Water Inc. for the quarterly period ending March 31, 2023;
2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;
3.	Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;
4.	The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal controls over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)	designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared;
b)	designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)	evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation;
d)	disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting;

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent function):

a)	all significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b)	any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.

Date: May 8, 2023
By:	/s/ Israel Abitbol
	Chief Financial Officer

EX-32.1

EXHIBIT 32.1

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND

PRINCIPAL FINANCIAL OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF THE

SARBANES-OXLEY ACT OF 2002

In connection with the Amendment No. 1 to Form 10-Q/A of 374Water Inc. for 374Water Inc., (the “Company”) for the period ended March 31, 2023, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), Yaacov Nagar, Chief Executive Officer, of the Company certify pursuant to 18 U.S.C. section 1350 of the Sarbanes-Oxley Act of 2002 that:

(1)	The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: May 8, 2023
By:	/s/ Yaacov Nagar
	Chief Executive Officer

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

EX-32.2

EXHIBIT 32.2

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND

PRINCIPAL FINANCIAL OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906 OF THE

SARBANES-OXLEY ACT OF 2002

In connection with the Amendment No. 1 to Form 10-Q/A of 374Water Inc. for 374Water Inc., (the “Company”) for the period ended March 31, 2023, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), Israel Abitbol, Chief Financial Officer, of the Company certify pursuant to 18 U.S.C. section 1350 of the Sarbanes-Oxley Act of 2002 that:

(1)	The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: May 8, 2023
By:	/s/ Israel Abitbol
	Chief Financial Officer

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

XML

Cover - shares	3 Months Ended
	Mar. 31, 2023	May 08, 2023
Cover [Abstract]
Entity Registrant Name	374WATER INC.
Entity Central Index Key	0000933972
Document Type	10-Q
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity Small Business	true
Entity Shell Company	false
Entity Emerging Growth Company	true
Entity Current Reporting Status	Yes
Document Period End Date	Mar. 31, 2023
Entity Filer Category	Non-accelerated Filer
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2023
Entity Ex Transition Period	false
Entity Common Stock Shares Outstanding		129,027,819
Document Quarterly Report	true
Document Transition Report	false
Entity File Number	000-27866
Entity Incorporation State Country Code	DE
Entity Tax Identification Number	88-0271109
Entity Address Address Line 1	701 W Main Street
Entity Address Address Line 2	Suite 410
Entity Address City Or Town	Durham
Entity Address State Or Province	NC
Entity Address Postal Zip Code	27701
City Area Code	919
Local Phone Number	888-8194
Security 12b Title	Common Stock, par value $0.0001
Trading Symbol	SCWO
Security Exchange Name	NASDAQ
Entity Interactive Data Current	Yes

XML

Condensed Consolidated Balance Sheets - USD ($)	Mar. 31, 2023	Dec. 31, 2022
Current Assets:
Cash	$ 9,153,161	$ 4,046,937
Accounts receivable, net of allowance of $191 and $0	26,188	0
Unbilled accounts receivable	1,672,454	918,164
Other accounts receivable	308,374	0
Inventory	1,788,019	1,660,710
Investments	1,960,761	1,944,464
Prepaid expenses	130,170	153,455
Total Current Assets	15,039,127	8,723,730
Long-Term Assets:
Equipment, net	140,857	143,079
Intangible asset, net	1,035,817	1,050,022
Total Long-Term Assets	1,176,674	1,193,101
Total Assets	16,215,801	9,916,831
Current Liabilities:
Accounts payable and accrued expenses	868,000	1,449,582
Deferred revenue	205,109	200,109
Other liabilities	0	13,528
Total Current Liabilities	1,073,109	1,663,219
Total Liabilities	1,073,109	1,663,219
Stockholders' Equity
Preferred stock: 50,000,000 convertible Series D preferred shares authorized; par value $0.0001 per share, nil issued and outstanding at March 31, 2023 and December 31, 2022	0	0
Common stock : 200,000,000 common shares authorized, par value $0.0001 per share, 128,840,421 and 126,702,545 shares outstanding at March 31, 2023 and December 31, 2022, respectively	12,883	12,669
Additional paid-in capital	24,619,639	16,110,221
Accumulated (deficit)	(9,490,325)	(7,849,982)
Accumulated other comprehensive loss	495	(19,296)
Total Stockholders' Equity	15,142,692	8,253,612
Total Liabilities and Stockholders' Equity	$ 16,215,801	$ 9,916,831

XML

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Mar. 31, 2023	Dec. 31, 2022
Condensed Consolidated Balance Sheets
Preferred Stock, Shares Authorized	50,000,000	50,000,000
Preferred Stock Par Value	$ 0.0001	$ 0.0001
Preferred Stock, Shares Issued	0	0
Preferred Stock, Shares Outstanding	0	0
Common Stock, Shares Authorized	200,000,000	200,000,000
Common Stock, Par Value	$ 0.0001	$ 0.0001
Common Stock, Shares Outstanding	128,840,421	126,702,545

XML

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Condensed Consolidated Statements of Operations (Unaudited)
Revenue	$ 801,458	$ 273,231
Cost of goods sold	720,146	247,986
Gross profit	81,312	25,245
Operating Expenses
Research and development	355,905	185,653
Compensation and related expenses	718,760	301,235
Professional fees	99,572	150,658
General and administrative	585,659	261,403
Total Operating Expenses	1,759,896	898,950
Loss from Operations	(1,678,584)	(873,705)
Other Income (Expense)
Interest income	37,859	840
Other income	382	7
Total Other Income (Expense)	38,241	847
Net Loss before Income Taxes	(1,640,343)	(872,858)
Provision for Income Taxes	0	0
Net Loss	(1,640,343)	(872,858)
Other comprehensive loss
Change in foreign currency translation	824	0
Change in unrealized loss on marketable securities	18,967	0
Total other comprehensive loss	19,791	0
Total comprehensive loss	$ (1,620,552)	$ (872,858)
Net Loss per Share - Basic and Diluted	$ (0.01)	$ (0.01)
Weighted Average Common Shares Outstanding - Basic and Diluted	127,146,695	126,499,142

XML

Condensed Consolidated Changes in Stockholders' Equity (Unaudited) - USD ($)	Total	Preferred Stock [Member]	Common Stock [Member]	Additional Paid-In Capital [Member]	Accumulated Deficit [Member]	Other Comprehensive Income [Member]
Balance, shares at Dec. 31, 2021		27,272	125,317,746
Balance, amount at Dec. 31, 2021	$ 12,327,085	$ 3	$ 12,531	$ 15,474,566	$ (3,160,015)	$ 0
Conversion of preferred shares to common shares, shares		(27,272)	1,363,149
Conversion of preferred shares to common shares, amount	(2)	$ (3)	$ 136	(135)	0	0
Stock-based compensation	97,558	0	0	97,558	0	0
Net loss	(872,858)	0	$ 0	0	(872,858)	0
Balance, shares at Mar. 31, 2022			126,680,895
Balance, amount at Mar. 31, 2022	11,551,783	0	$ 12,667	15,571,989	(4,032,873)	0
Balance, shares at Dec. 31, 2022			126,702,545
Balance, amount at Dec. 31, 2022	8,253,612	0	$ 12,669	16,110,221	(7,849,982)	(19,296)
Stock-based compensation	214,924	0	0	214,924	0	0
Net loss	(1,640,343)	0	$ 0	0	(1,640,343)	0
Issuance of shares of common stock, shares			2,137,876
Issuance of shares of common stock, amount	8,294,708	0	$ 214	8,294,494	0	0
Foreign currency gain (Loss)	824	0	0	0	0	824
Unrealized gain (loss) on investments	18,967	0	$ 0	0	0	18,967
Balance, shares at Mar. 31, 2023			128,840,421
Balance, amount at Mar. 31, 2023	$ 15,142,692	$ 0	$ 12,883	$ 24,619,639	$ (9,490,325)	$ 495

XML

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Cash Flows from Operating Activities
Net loss	$ (1,640,343)	$ (872,858)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization expense	29,105	16,458
Stock based compensation	214,924	97,558
Change in foreign currency translation	824	0
Changes in operating assets and liabilities:
Accounts receivable	(26,188)	0
Unbilled accounts receivable	(754,290)	0
Other accounts receivable	(308,374)	0
Inventory	(127,309)	0
Prepaid expenses	23,285	(50,599)
Accounts payable and accrued expenses	(581,582)	81,059
Deferred revenue	5,000	763,333
Other liabilities	(13,528)	(20,238)
Cash Provided by (Used In) Operating Activities	(3,178,476)	115,911
Cash Flows from Investing Activities
Purchase of equipment	(7,303)	(3,291)
Increase in intangible assets	(2,705)	0
Cash Provided by (Used In) Investing Activities	(10,008)	(3,291)
Cash Flow from Financing Activities
Proceeds from the issuance of common stock	8,294,708	0
Cash Provided by Financing Activities	8,294,708	0
Net Increase in Cash	5,106,224	112,620
Cash, Beginning of the Period	4,046,937	11,131,175
Cash, End of the Period	9,153,161	11,243,795
NON-CASH FINANCING ACTIVITIES
Conversion of preferred stock to common stock	$ 0	$ 133

XML

Nature of Business and Presentation of Financial Statements

3 Months Ended

Mar. 31, 2023

Nature of Business and Presentation of Financial Statements

Nature of Business and Presentation of Financial Statements

Note 1 – Nature of Business and Presentation of Financial Statements

Description of the Company

374Water Inc. (the “Company”, “374Water”, “We”, or “Our”) is a Delaware corporation which was formed in September 2005 as PowerVerde, Inc. At that time, the Company was focused on developing, commercializing and marketing a series of unique electric generating power systems designed to produce electrical power with zero emissions or waste byproducts, based on a pressure-driven expander motor and related organic rankine cycle technology.

On April 16, 2021, the Company entered into an Agreement and Plan of Merger (the “Merger”) with 374Water Inc., a privately held company based in Durham, North Carolina, (“374Water Private Company”) and 374Water Acquisition Corp., a newly-formed wholly-owned subsidiary of PowerVerde.

Following the Merger, 374Water offers a disruptive technology that transforms all wet wastes such as sewage sludge, biosolids, food waste, hazardous and non-hazardous waste, and forever chemicals (e.g., PFAS) into recoverable resources by focusing on waste as a valuable resource for water, energy, and minerals. We are pioneers in a new era of waste management that supports a circular economy and enables organizations to achieve their environment, social, and governance (ESG) goals. Our vision is a world without waste and our mission is to help create and preserve a clean and healthy environment that sustains life.

Presentation of Financial Statements

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America and the rules and regulations of the United States Securities and Exchange Commission (the “SEC”) for interim financial information. It is management’s opinion that the accompanying unaudited condensed consolidated financial statements are prepared in accordance with instructions for Form 10-Q and include all adjustments (consisting only of normal recurring accruals) which are necessary for a fair presentation of the results for the periods presented. Certain information and footnote disclosures normally included in the consolidated financial statements prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") have been condensed or omitted. It is suggested that these condensed consolidated financial statements be read in conjunction with the Annual Report on Form 10-K of 374Water Inc. (“374 Water," “we,” “us,” “our,” or the “Company”) as of and for the year ended December 31, 2022 filed with the Securities and Exchange Commission (“SEC”) on March 16, 2023.

The results of operations for the three months ended March 31, 2023, are not necessarily indicative of the results to be expected for the full year or for future periods. The condensed consolidated financial statements include the accounts of 374Water Inc., 374Water Systems Inc, and 374Water Sustainability Israel LTD, each a wholly-owned subsidiary of 374 Water. Intercompany balances and transactions have been eliminated in consolidation.

XML

Summary of Significant Accounting Policies

3 Months Ended

Mar. 31, 2023

Summary of Significant Accounting Policies

Summary of Significant Accounting Policies

Note 2 – Summary of Significant Accounting Policies

Cash and Cash Equivalents and Marketable Securities

The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents. The Company held $2,696,107 and $1,182,412 in cash equivalents as of March 31, 2023 and December 31, 2022, respectively.

The Company held marketable securities as of March 31, 2023 as noted in the following table:

	Adjusted Cost		Unrealized Losses		Fair Value		Cash and Cash Equivalents		Current Marketable Securities		Non-Current Marketable Securities
Cash	$	9,153,161		—	$	9,153,161	$	9,153,161		—		—
Level 2:
U.S. Treasury securities	$	1,960,761	$	8,049	$	1,952,712	$	—	$	1,952,712		—
Total	$	11,113,922	$	8,049	$	11,105,873	$	9,153,161	$	1,952,712		—

The Company held marketable securities as of December 31, 2022 as noted in the following table:

	Adjusted Cost		Unrealized Losses		Fair Value		Cash and Cash Equivalents		Current Marketable Securities		Non-Current Marketable Securities
Cash	$	4,046,937		—	$	4,046,937	$	4,046,937		—		—
Level 2:
U.S. Treasury securities	$	1,963,432	$	18,968	$	1,944,464	$	—	$	1,944,464		—
Total	$	6,010,369	$	18,968	$	5,991,401	$	4,046,937	$	1,944,464		—

Accounting Standards Codification (ASC) Topic 820 “Fair Value Measurements” establishes a fair value hierarchy that prioritizes the information used to develop those assumptions. The fair value hierarchy is as follows:

Level 1 Inputs - Unadjusted quoted prices in active markets for identical assets or liabilities that the entity has the ability to access at the measurement date.

Level 2 Inputs - Fair value estimates are based on observable inputs other than quoted prices in active markets for identical assets and liabilities, quoted prices for identical or similar assets or liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

Level 3 Inputs - Unobservable inputs for determining the fair values of assets or liabilities that reflect an entity’s own assumptions about the assumptions that market participants would use in pricing the assets or liabilities.

The following is a description of valuation methodologies used for assets and liabilities recorded at an amortized cost basis:

∙ Investment Securities Held-to-Maturity. Investment securities held-to-maturity (“HTM”) are recorded at their initial cost, and any discount or premium amortized over the remaining life of the security. The carrying value of the investment is adjusted for the amortized amount of any discount or premium at each reporting period.

Accounts Receivable

Accounts receivables consist of balances due from service revenues, unbilled accounts receivables which is for revenues earned but not yet billed, and other receivables relating to common stock subscription purchases where the stock has been transferred but the cash has not been received. The Company monitors accounts receivable and provides allowances when considered necessary. At March 31, 2023 and December 31, 2022, accounts receivable were considered to be fully collectible but in accordance with the allowance for credit losses, the Company recorded an allowance for bad debt based on a reserve of current and aged receivables. Accordingly, an allowance for doubtful accounts of $191 and $0 was recorded as of March 31, 2023 and December 31, 2022, respectively. 

Accounts Receivable

Accounts receivables consist of balances due from sales and service revenues and accrued interest from the investment account. 

Unbilled Accounts Receivable

Unbilled accounts receivables consist of balances due from sales and service revenue earned but not yet billed. 

Other Accounts Receivable

Other accounts receivables consist of cash due from the investment bank after the sale of common stock that has not cleared the bank yet by the end of the period.  The cash is transferred from the investment bank to the Company typically within 3 to 5 days of the sale of common stock. 

Accounts receivable allowance for credit losses

The activity related to the accounts receivable allowance for credit losses was as follows:

Name	Three Months Ending at March 31, 2023		Three Months Ending at March 31, 2022
Beginning balance	$	—	$	—
Current period provision		191		—
Write-offs		—		—
Ending Balance	$	191	$	—

Inventories

Inventories are stated at the lower of cost or net realizable value. Cost is determined on a first-in, first-out basis. The majority of our inventory is raw materials and work in progress.  Net realizable value is the value of an asset that can be realized upon the sale of the asset, less a reasonable estimate of the costs associated with either the eventual sale or the disposal of the asset in question.  We utilize third-party suppliers to produce our products. Costs associated with fabrication, and other costs associated with the manufacturing of products, are recorded as inventory. We periodically evaluate the carrying value of our inventories in relation to estimated forecasts of product demand, which takes into consideration the life cycle of product releases. When quantities on hand exceed estimated sales forecasts, we perform an analysis to determine if a write-down for such excess inventories is required.  Once inventory has been written down, it creates a new cost basis for inventory.  Inventories are classified as current assets in accordance with recognized industry practice.

Property and Equipment

Property and Equipment is recorded at cost. Depreciation is computed using the straight-line method and an estimated useful life of three years. Expenses for maintenance and repairs are charged to expense as incurred.  Depreciation expense related to property and equipment was as follows:

	Period Ended March 31,
	2023		2022
Depreciation	$	9,525	$	235

Intangible Assets

Intangible assets are subject to amortization, and any impairment is determined in accordance with ASC 360, “Property, Plant, and Equipment.” Intangible assets are stated at historical cost and amortized over their estimated useful lives. The Company uses a straight-line method of amortization unless a method that better reflects the pattern in which the economic benefits of the intangible asset are consumed or otherwise used up can be reliably determined. As of March 31, 2023 and December 31, 2022, there was no impairment.

Long-Lived Assets

The Company reviews long-lived assets, including intangible assets with finite lives, for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The Company uses an estimate of the undiscounted cash flows over the remaining life of its long-lived assets, or related group of assets where applicable, in measuring whether the assets to be held and used will be realizable. Recoverability of assets held and used is measured by a comparison of the carrying amount to the future undiscounted expected net cash flows to be generated by the asset. As of March 31, 2023 and December 31, 2022, there were no impairments.

Concentrations of Credit Risk

Financial instruments that potentially subject the Company to credit risk consist of cash and cash equivalents, and marketable securities. Deposits with financial institutions are insured, up to certain limits, by the Federal Deposit Insurance Corporation (“FDIC”). The Company’s cash deposits often exceed the FDIC insurance limit; however, all deposits are maintained with high credit quality institutions and the Company has not experienced any losses in such accounts. The financial condition of financial institutions is periodically reassessed, and the Company believes the risk of any loss is minimal. The Company believes the risk of any loss on cash due to credit risk is minimal. Furthermore, we perform ongoing credit evaluations of our customers and generally do not require collateral.

Significant customers and suppliers are those that account for greater than 10% of the Company’s revenues and purchases.  Our customer revenue for one customer made up over 90% of revenue for the period ended March 31, 2023 and year ended December 31, 2022. In 2023 and 2022, the Company purchased a substantial portion of manufacturing services from one third party vendor, Merrell Bros Fabrication, LLC.

Revenue Recognition

The Company follows the revenue standards of Codification (ASC) Topic 606: “Revenue from Contracts with Customers (Topic 606).” The core principle of this Topic is that an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Revenue is recognized in accordance with that core principle by applying the following five steps: 1) identify the contracts with a customer; 2) identify the performance obligations in the contract; 3) determine the transaction price; 4) allocate the transaction price to the performance obligations; and 5) recognize revenue when (or as) we satisfy a performance obligation using the input method.

The Company’s performance obligations are satisfied over time over the life of the contract. The Company's revenue arrangements consist of a single performance obligation to transfer services. Revenue is recognized over time by measuring the progress toward complete satisfaction of the performance obligation using specific milestones. These milestones within the contract are assigned revenue recognition percentages, based on overall expected cost-plus margin estimates of those milestones compared to the total cost of the contract. Contract revenues are recognized in the proportion that contract costs incurred bear to total estimated costs. This method is used because management considers the input method to be the best available measure of progress on these contracts. Contract costs include all direct material and labor and subcontractor costs and those indirect costs related to contract performance, such as indirect labor, supplies, tools, repairs, and depreciation. General, selling, and administrative costs are charged to expense as incurred.

We also record as revenue all amounts billed to customers for shipping and handling costs and record the actual shipping costs as a component of cost of revenues. Reimbursements received from customers for out-of-pocket expenses are recorded as revenues, with related costs recorded as cost of revenues. We present revenues net of any taxes collected from customers and remitted to government authorities.

Revenues for the period ended March 31, 2023 in the amount of $793,458 was generated from the sale of the AirSCWO system and $8,000 was generated from the sale of treatability services. 

Revenues for the year ended December 31, 2022 in the amount of $2,952,020 was generated from the sale of the AirSCWO system and $63,501 was generated from the sale of treatability services. 

Stock-based Compensation

The Company has accounted for stock-based compensation under the provisions of ASC Topic 718 – “Stock Compensation” which requires the use of the fair-value based method to determine compensation for all arrangements under which employees and others receive shares of stock or equity instruments (stock options and common stock purchase warrants). The fair value of each stock option award is estimated on the date of grant using the Black-Scholes valuation model that uses assumptions for expected volatility, expected dividends, expected term, and the risk-free interest rate. Expected volatilities are based on historical volatility of peer companies and other factors estimated over the expected term of the stock options. The expected term of options granted is derived using the “simplified method” which computes expected term as the average of the sum of the vesting term plus the contract term. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for the period of the expected term.

Income Tax Policy

The Company accounts for income taxes using the liability method prescribed by ASC 740 - Income Taxes. Under this method, deferred tax assets and liabilities are determined based on the difference between the financial reporting and tax bases of assets and liabilities using enacted tax rates that will be in effect in the year in which the differences are expected to reverse. The Company records a valuation allowance to offset deferred tax assets if, based on the weight of available evidence, it is more-likely-than-not that some portion, or all, of the deferred tax assets will not be realized. The effect on deferred taxes of a change in tax rates is recognized as income or loss in the period that includes the enactment date.

Accounting for Uncertainty in Income Taxes

The Company follows the provisions of ASC Topic 740-10, “Accounting for Uncertainty in Income Taxes” which clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. This topic also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition. There were no uncertain tax positions as of March 31, 2023 and December 31, 2022.

Research and Development Costs

The Company’s research and development costs are expensed in the period in which they are incurred. Such expenditures amounted to $355,905 and $185,653 for the three months ended March 31, 2023, and 2022, respectively.

Earnings (Loss) Per Share

Earnings (loss) per share is computed in accordance with ASC Topic 260, “Earnings per Share” Basic weighted-average number of shares of common stock outstanding for the years ended March 31, 2023 and December 31, 2022 include the shares of the Company issued and outstanding during such periods, each on a weighted average basis. The basic weighted average number of shares common stock outstanding excludes common stock equivalent incremental shares, while diluted weighted average number of shares outstanding includes such incremental shares. However, as the Company was in a loss position for all periods presented, basic and diluted weighted average shares outstanding are the same, as the inclusion of the incremental shares would be anti-dilutive.  As of March 31, 2023 and December 31, 2022, there were the following potentially dilutive securities that were excluded from diluted net loss per share because their effect would be antidilutive: options for 13,025,000 shares of common stock and 1,250,000 warrants. 

Financial Instruments

The Company carries cash, accounts receivable, accounts payable and accrued expenses, at historical costs. The respective estimated fair values of these assets and liabilities approximate carrying values / useful lives of equipment and intangible assets due to their current nature.

Foreign Currency Translation

All assets and liabilities of the Companies’ locations whose accounts are denominated in foreign currency are translated into United States dollars at appropriate year-end current exchange rates.  All income and expense accounts of those locations are translated at the average exchange rate for each period.  The foreign currency translation amounts for the period ended March 31, 2023 and the year ended December 31, 2022 are included in accumulated comprehensive income on the consolidated statement of changes in equity.

Use of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates in the accompanying financial statements include the fair value of equity-based compensation, revenue, fair value of intangible assets, useful lives of intangible assets, capital raise transactions, and valuation allowance against deferred tax assets.

Recent Accounting Pronouncements

In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which amends guidance on reporting credit losses for assets held at amortized cost basis and available for sale debt securities.  For assets held at amortized cost basis, Topic 326 eliminates the probable initial recognition threshold in current GAAP and, instead, requires an entity to reflect its current estimate of all expected credit losses.  The allowance for credit losses is a valuation account that is deducted from the amortized cost basis of the financial assets to present the net amount expected to be collected.  For available for sale debt securities, credit losses should be measured in a manner similar to current GAAP, however Topic 326 will require that credit losses be presented as an allowance rather than as a write-down.  This ASU affects entities holding financial assets and net investment in leases that are not accounted for at fair value through net income. The amendments affect loans, debt securities, trade receivables, net investments in leases, off balance sheet credit exposures, reinsurance receivables, and any other financial assets not excluded from the scope that have the contractual right to receive cash. The amendments in this update are effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years.  The Company has completed its assessment on the impact of the adoption of the ASU on its financial statements, disclosure requirements and methods of adoption and noted that there is no impact at this time for our HTM investments and noted a small adjustment for the allowance for bad debt which has been recorded as of March 31, 2023. 

The Company considers the applicability and impact of all recently issued accounting pronouncements. Recent accounting pronouncements not specifically identified in our disclosures are either not applicable to the Company or are not expected to have a material effect on our financial condition or results of operations.

XML

Liquidity Capital Resources and Going Concern

3 Months Ended

Mar. 31, 2023

Liquidity Capital Resources and Going Concern

Liquidity, Capital Resources and Going Concern

Note 3 – Liquidity, Capital Resources and Going Concern

As of March 31, 2023, the Company had working capital of $13,966,018 compared to working capital of $7,060,511 at December 31, 2022.  As of March 31, 2023, the Company had an accumulated deficit of $9,490,325. For the three months ended March 31, 2023, the Company had a net loss of $1,640,343 and used $3,178,476 of net cash in operations for the period.

The Company believes it has sufficient cash-on-hand (including its marketable securities described in Note 2 above) for the Company to meet its financial obligations as they come due at least the next 12 months from the date of the report. 

XML

Inventory

3 Months Ended

Mar. 31, 2023

Inventory

Inventory

Note 4 – Inventory

Inventory consists of:

Name	Balance at March 31, 2023		Balance at December 31, 2022
Raw materials	$	533,925	$	755,218
Work-in-process		1,254,094		905,492
Total	$	1,788,019	$	1,660,710

As of March 31, 2023 and December 31, 2022, the Company noted no inventory impairment and there were no inventory write downs recorded. 

XML

Intangible Assets

3 Months Ended

Mar. 31, 2023

Intangible Assets

Intangible Assets

Note 5 – Intangible Assets

Intangible assets are recorded at cost and consist of the License Agreement with Duke University. The Company issued Duke University a small number of shares of common stock estimated to have a fair value of $1,073,529 as consideration for granting the Company the license based on the Company’s common stock market price on the date the License Agreement was executed (see Note 9). Intangible assets are comprised of the following as of March 31, 2023 and December 31, 2022:

Name	Estimated Life	Balance at December 31, 2022		Additions		Amortization		Balance at March 31, 2023
License agreement	17 Years	$	964,965	$	—	$	15,787	$	949,178
Patents	20 Years		85,057		2,705		1,123		86,639
Total		$	1,050,022	$	2,705	$	16,910	$	1,035,817

Name	Estimated Life	Balance at December 31, 2021		Additions		Amortization		Balance at December 31, 2022
License agreement	17 Years	$	1,028,114	$	-	$	63,149	$	964,965
Patents	20 Years		34,742		52,292		1,977		85,057
Total		$	1,062,856	$	52,292	$	65,126	$	1,050,022

Amortization expense for the three months ended March 31, 2023 and 2022, was $16,910 and $16,458, respectively.

Estimated future amortization expense as of March 31, 2023:

	March 31,
	2023
2023	$	50,827
2024		67,769
2025		67,769
2026		67,769
2027		67,769
Thereafter		713,914
Intangible assets, Net	$	1,035,817

XML

Revenue

3 Months Ended

Mar. 31, 2023

Revenue

Revenue

Note 6 – Revenue 

The following is a summary of our revenues by type for the period ended March 31, 2023 and March 31, 2022:

Name	Balance at March 31, 2023		%			Balance at March 31, 2022		%
Equipment revenue	$	793,458		99	%	$	273,231		100	%
Service revenue		8,000		1	%		—		—	%
Total	$	801,458		100	%	$	273,231		100	%

Unearned Revenue

The following is a summary of our unearned revenue activity for the period ended March 31, 2023 and year ended December 31, 2022: 

Name	Balance at March 31, 2023		Balance at December 31, 2022
Unearned revenue at beginning of year	$	200,109	$	—
Billings deferred		5,000		1,467,189
Recognition of prior unearned revenue		—		(1,267,080	)
Unearned revenue at end of year	$	205,109	$	200,109

Unbilled Accounts Receivable

The following is a summary of our unbilled accounts receivable activity for the period ended March 31, 2023 and the year ended December 31, 2022:

Name	Balance at March 31, 2023			Balance at December 31, 2022
Unbilled accounts receivable at beginning of year	$	918,164		$	—
Services performed but unbilled		793,458			918,164
Services billed		(39,168	)		—
Unbilled accounts receivable at end of year	$	1,672,454		$	918,164

XML

Stockholder Equity

3 Months Ended

Mar. 31, 2023

Stockholder Equity

Stockholder' Equity

Note 7 – Stockholder’ Equity

The Company is authorized to issue 50,000,000 preferred stock shares and 200,000,000 common stock shares both with a par value of $0.0001.

Preferred Stock

On October 30, 2020, the Company designated 1,000,000 shares as Series D Convertible Preferred Stock with a par value of $0.0001.

On April 16, 2021, the Company closed on a private placement of 440,125 shares of Series D Convertible Preferred Stock (the “Preferred Stock'') with a par value of $0.0001, yielding gross proceeds of $6,551,691 (the “Private Placement”) and settlement of a $50,000 liability for Preferred Stock shares. The Private Placement proceeds will be used for working capital, primarily for the development, manufacturing and commercialization of 374Water’s Air SCWO systems. The Preferred Stock has a stated value of $15 per share, is convertible into common stock at $0.30 per share and has voting rights based on the underlying shares of common stock. Upon liquidation of the Company, the Preferred Stockholders have a liquidation preference before any assets can be distributed to common stockholders. All of the Preferred Stock were sold pursuant to an exemption from registration requirements under Regulation D and/or Section 4(2) of the Securities Act of 1933, as amended. On September 29, 2021, 412,853 shares of Preferred Stock were converted into 20,642,667 shares of common stock.  On January 12, 2022, the Company converted the remaining 27,272 shares of Preferred Stock to 1,363,149 shares of common stock.  As of March 31, 2023, there were no shares of Preferred Stock issued and outstanding.

Common Stock

The holders of common stock are entitled to one vote per share on all matters submitted to a vote of shareholders, including the directors’ election. There is no right to cumulative voting in the election of directors. The holders of common stock are entitled to any dividends that may be declared by the board of directors out of funds legally available for payment of dividends subject to the prior rights of holders of preferred stock and any contractual restrictions the Company has against the payment of dividends on common stock. In the event of our liquidation or dissolution, holders of common stock are entitled to share ratably in all assets remaining after payment of liabilities and the liquidation preferences of any outstanding shares of preferred stock. Holders of common stock have no preemptive rights and have no right to convert their common stock into any other securities. As of March 31, 2023, there were 128,840,421 shares of common stock issued and outstanding.

In December 2022, the Company entered into an equity distribution agreement with an underwriter pursuant to which the Company may offer and sell shares of its common stock from time to time through the underwriter as its sales agent. Sales of common stock, if any, will be made at market prices by any method permitted by law deemed to be an “at-the-market” offering as defined in Rule 415 promulgated under the Securities Act of 1933, as amended. The Company has no obligation to sell any shares of common stock under the equity distribution agreement, and may at any time suspend offers under the equity distribution agreement, in whole or in part, or terminate the equity distribution agreement.

During the three months ended March 31, 2023, a total of 2,137,876 shares of common stock have been sold pursuant to the equity distribution agreement resulting in a total of $8.35 million in proceeds, net of $0.11 million of commission fees and $0.05 million of accounting and legal fees. As of March 31, 2023, $91.5 million remained available under the Company’s at-the-market public facility, subject to various limitations.

Stock-based compensation

During the three months ended March 31, 2023, and 2022, the Company recorded stock-based compensation of $214,924 and $97,558, respectively, related to common stock issued or vested options to employees and various consultants of the Company. For the three months ended March 31, 2023, $189,283 was charged as general and administrative expenses and $25,641 as research and development expenses in the accompanying condensed consolidated statements of operations.  For the three months ended March 31, 2022, $93,868 was charged as general and administrative expenses and $3,690 as research and development expenses in the accompanying condensed consolidated statements of operations.

Stock Options

Stock option activity for the three months ended March 31, 2023 is summarized as follows:

	Shares		Weighted Average Exercise Price		Aggregate Intrinsic Value		Weighted Average Remaining Contractual Life (Years)
Options outstanding at December 31, 2022		12,752,000	$	0.62	$	28,543,370		5.09
Granted		273,000		3.09		—		—
Exercised		—		—		—		—
Expired/forfeit		—		—		—		—
Options outstanding at March 31, 2023		13,025,000		0.67	$	52,705,860		4.93

Stock option activity for the three months ended March 31, 2022 is summarized as follows:

	Shares		Weighted Average Exercise Price		Aggregate Intrinsic Value		Weighted Average Remaining Contractual Life (Years)
Options outstanding at December 31, 2021		12,300,000	$	0.37	$	30,504,000		5.62
Granted		360,000		3.33		—		—
Exercised		—		—		—		—
Expired/forfeit		—		—		—		—
Options outstanding at March 31, 2022		12,660,000		0.45	$	45,576,000		5.39

Total unrecognized compensation associated with these unvested options is approximately $2,213,723 which will be recognized over a period of four years.

The fair value of these options granted were estimated on the date of grant, using the Black-Scholes option-pricing model with the following assumptions:

	March 31, 2023			March 31, 2022
Dividend yield		0.00	%		0.00	%
Expected life	5.45 – 5.79 Years			5.65 – 5.75 Years
Expected volatility	35.24 – 35.88		%	37.73 – 39.18		%
Risk-free interest rate	3.58 – 3.97		%	1.44 – 2.12		%

Stock Warrants

As of March 31, 2023, there were 1,250,000 warrants outstanding which relate to the Series 1 offering executed in December 2021, where investors were offered a warrant for every two common shares purchased during the offering at an exercise price of $2.50 per share. The intrinsic value of all outstanding warrants as of March 31, 2023 was $2,775,000 based on the market price of our common stock of $4.72 per share, which was the Company’s closing per share common stock price as reported on Nasdaq as of March 31, 2023.

During the three months ended March 31, 2023, no warrants were issued or exercised. As of March 31, 2023, there are 1,250,000 outstanding warrants. 

 A summary of warrant activity during the three months ended March 31, 2023, is as follows:

	Shares		Weighted Average Exercise Price		Aggregate Intrinsic Value		Weighted Average Remaining Contractual Life (Years)
Balance at December 31, 2022		1,250,000		2.50	$	450,000		1.96
Issued		—		—		—		—
Exercised		—		—		—		—
Balance at March 31, 2023		1,250,000		2.50	$	2,775,000		1.72

XML

Related Party Transactions

3 Months Ended

Mar. 31, 2023

Related Party Transactions

Related Party Transactions

Note 8 - Related Party Transactions

In 2021, the Company entered into an agreement to fabricate and manufacture the AirSCWO systems with Merrell Bros. Holding Company. As part of the agreement, the Company appointed Terry Merrell to its board of directors. As of March 31, 2023, Merrell Bros. or their affiliates own stock in excess of 5% of the outstanding common stock.  As of March 31, 2023, the Company incurred $535,201 in related party expenses, of which $514,399 was related to the manufacturing of the AirSCWO systems. As of March 31, 2023, there is an accrual of $446,081 in related party expenses, of which $432,582 related to the manufacturing of the AirSCWO systems.

XML

Commitments

3 Months Ended

Mar. 31, 2023

Commitments

Commitments

Note 9 - Commitments

The patented technology underlying 374Water’s supercritical water oxidation (SCWO) units, which was developed principally through the efforts of Messrs. Nagar and Deshusses at the facilities of Duke University, Durham, North Carolina (“Duke”), where Dr. Deshusses is a professor. The SCWO technology is licensed to 374Water pursuant to a worldwide license agreement with Duke executed on April 16, 2021 (the “License Agreement”). In connection with the License Agreement, 374Water also executed an equity transfer Agreement with Duke pursuant to which Duke received a small number of common stock in the Company (See Notes 5 and 7). Under the terms of the License Agreement, the Company is required to make royalty payments based on a percentage of licensed product sales, as defined in the License Agreement which is triggered by the sale of licensed products. Further, the Company is also required to pay royalties on a percentage of sublicensing fees. The Company will reimburse Duke for any ongoing patent expenses incurred. During the three-month period ending March 31, 2023, the Company has not incurred any expenses in connection with this License Agreement. The Company may terminate the license agreement anytime by providing Duke 60 days’ written notice.

XML

Subsequent Events

3 Months Ended

Mar. 31, 2023

Subsequent Events

Subsequents Events

Note 10 - Subsequent Events

From April 1, 2023 through May 5, 2023, we raised approximately $717,835 in net proceeds through an at-the-market equity offering of 152,285 shares of common stock.  Pursuant to the at-the-market equity offering, we may issue up to $100 million of common stock, less the amounts already raised.

XML

Summary of Significant Accounting Policies (Policies)

3 Months Ended

Mar. 31, 2023

Summary of Significant Accounting Policies

Cash and Cash Equivalents and Marketable Securities

The Company considers all highly liquid investments purchased with an original maturity of three months or less to be cash equivalents. The Company held $2,696,107 and $1,182,412 in cash equivalents as of March 31, 2023 and December 31, 2022, respectively.

The Company held marketable securities as of March 31, 2023 as noted in the following table:

	Adjusted Cost		Unrealized Losses		Fair Value		Cash and Cash Equivalents		Current Marketable Securities		Non-Current Marketable Securities
Cash	$	9,153,161		—	$	9,153,161	$	9,153,161		—		—
Level 2:
U.S. Treasury securities	$	1,960,761	$	8,049	$	1,952,712	$	—	$	1,952,712		—
Total	$	11,113,922	$	8,049	$	11,105,873	$	9,153,161	$	1,952,712		—

The Company held marketable securities as of December 31, 2022 as noted in the following table:

	Adjusted Cost		Unrealized Losses		Fair Value		Cash and Cash Equivalents		Current Marketable Securities		Non-Current Marketable Securities
Cash	$	4,046,937		—	$	4,046,937	$	4,046,937		—		—
Level 2:
U.S. Treasury securities	$	1,963,432	$	18,968	$	1,944,464	$	—	$	1,944,464		—
Total	$	6,010,369	$	18,968	$	5,991,401	$	4,046,937	$	1,944,464		—

Accounting Standards Codification (ASC) Topic 820 “Fair Value Measurements” establishes a fair value hierarchy that prioritizes the information used to develop those assumptions. The fair value hierarchy is as follows:

Level 1 Inputs - Unadjusted quoted prices in active markets for identical assets or liabilities that the entity has the ability to access at the measurement date.

Level 2 Inputs - Fair value estimates are based on observable inputs other than quoted prices in active markets for identical assets and liabilities, quoted prices for identical or similar assets or liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

Level 3 Inputs - Unobservable inputs for determining the fair values of assets or liabilities that reflect an entity’s own assumptions about the assumptions that market participants would use in pricing the assets or liabilities.

The following is a description of valuation methodologies used for assets and liabilities recorded at an amortized cost basis:

∙ Investment Securities Held-to-Maturity. Investment securities held-to-maturity (“HTM”) are recorded at their initial cost, and any discount or premium amortized over the remaining life of the security. The carrying value of the investment is adjusted for the amortized amount of any discount or premium at each reporting period.

Accounts Receivable

Accounts receivables consist of balances due from service revenues, unbilled accounts receivables which is for revenues earned but not yet billed, and other receivables relating to common stock subscription purchases where the stock has been transferred but the cash has not been received. The Company monitors accounts receivable and provides allowances when considered necessary. At March 31, 2023 and December 31, 2022, accounts receivable were considered to be fully collectible but in accordance with the allowance for credit losses, the Company recorded an allowance for bad debt based on a reserve of current and aged receivables. Accordingly, an allowance for doubtful accounts of $191 and $0 was recorded as of March 31, 2023 and December 31, 2022, respectively. 

Accounts Receivable

Accounts receivables consist of balances due from sales and service revenues and accrued interest from the investment account. 

Unbilled Accounts Receivable

Unbilled accounts receivables consist of balances due from sales and service revenue earned but not yet billed. 

Other Accounts Receivable

Other accounts receivables consist of cash due from the investment bank after the sale of common stock that has not cleared the bank yet by the end of the period.  The cash is transferred from the investment bank to the Company typically within 3 to 5 days of the sale of common stock. 

Accounts receivable allowance for credit losses

The activity related to the accounts receivable allowance for credit losses was as follows:

Name	Three Months Ending at March 31, 2023		Three Months Ending at March 31, 2022
Beginning balance	$	—	$	—
Current period provision		191		—
Write-offs		—		—
Ending Balance	$	191	$	—

Inventories

Inventories are stated at the lower of cost or net realizable value. Cost is determined on a first-in, first-out basis. The majority of our inventory is raw materials and work in progress.  Net realizable value is the value of an asset that can be realized upon the sale of the asset, less a reasonable estimate of the costs associated with either the eventual sale or the disposal of the asset in question.  We utilize third-party suppliers to produce our products. Costs associated with fabrication, and other costs associated with the manufacturing of products, are recorded as inventory. We periodically evaluate the carrying value of our inventories in relation to estimated forecasts of product demand, which takes into consideration the life cycle of product releases. When quantities on hand exceed estimated sales forecasts, we perform an analysis to determine if a write-down for such excess inventories is required.  Once inventory has been written down, it creates a new cost basis for inventory.  Inventories are classified as current assets in accordance with recognized industry practice.

Property and Equipment

Property and Equipment is recorded at cost. Depreciation is computed using the straight-line method and an estimated useful life of three years. Expenses for maintenance and repairs are charged to expense as incurred.  Depreciation expense related to property and equipment was as follows:

	Period Ended March 31,
	2023		2022
Depreciation	$	9,525	$	235

Intangible Assets

Intangible assets are subject to amortization, and any impairment is determined in accordance with ASC 360, “Property, Plant, and Equipment.” Intangible assets are stated at historical cost and amortized over their estimated useful lives. The Company uses a straight-line method of amortization unless a method that better reflects the pattern in which the economic benefits of the intangible asset are consumed or otherwise used up can be reliably determined. As of March 31, 2023 and December 31, 2022, there was no impairment.

Long-lived Assets

The Company reviews long-lived assets, including intangible assets with finite lives, for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. The Company uses an estimate of the undiscounted cash flows over the remaining life of its long-lived assets, or related group of assets where applicable, in measuring whether the assets to be held and used will be realizable. Recoverability of assets held and used is measured by a comparison of the carrying amount to the future undiscounted expected net cash flows to be generated by the asset. As of March 31, 2023 and December 31, 2022, there were no impairments.

Concentrations of Credit Risk

Financial instruments that potentially subject the Company to credit risk consist of cash and cash equivalents, and marketable securities. Deposits with financial institutions are insured, up to certain limits, by the Federal Deposit Insurance Corporation (“FDIC”). The Company’s cash deposits often exceed the FDIC insurance limit; however, all deposits are maintained with high credit quality institutions and the Company has not experienced any losses in such accounts. The financial condition of financial institutions is periodically reassessed, and the Company believes the risk of any loss is minimal. The Company believes the risk of any loss on cash due to credit risk is minimal. Furthermore, we perform ongoing credit evaluations of our customers and generally do not require collateral.

Significant customers and suppliers are those that account for greater than 10% of the Company’s revenues and purchases.  Our customer revenue for one customer made up over 90% of revenue for the period ended March 31, 2023 and year ended December 31, 2022. In 2023 and 2022, the Company purchased a substantial portion of manufacturing services from one third party vendor, Merrell Bros Fabrication, LLC.

Revenue Recognition

The Company follows the revenue standards of Codification (ASC) Topic 606: “Revenue from Contracts with Customers (Topic 606).” The core principle of this Topic is that an entity recognizes revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Revenue is recognized in accordance with that core principle by applying the following five steps: 1) identify the contracts with a customer; 2) identify the performance obligations in the contract; 3) determine the transaction price; 4) allocate the transaction price to the performance obligations; and 5) recognize revenue when (or as) we satisfy a performance obligation using the input method.

The Company’s performance obligations are satisfied over time over the life of the contract. The Company's revenue arrangements consist of a single performance obligation to transfer services. Revenue is recognized over time by measuring the progress toward complete satisfaction of the performance obligation using specific milestones. These milestones within the contract are assigned revenue recognition percentages, based on overall expected cost-plus margin estimates of those milestones compared to the total cost of the contract. Contract revenues are recognized in the proportion that contract costs incurred bear to total estimated costs. This method is used because management considers the input method to be the best available measure of progress on these contracts. Contract costs include all direct material and labor and subcontractor costs and those indirect costs related to contract performance, such as indirect labor, supplies, tools, repairs, and depreciation. General, selling, and administrative costs are charged to expense as incurred.

We also record as revenue all amounts billed to customers for shipping and handling costs and record the actual shipping costs as a component of cost of revenues. Reimbursements received from customers for out-of-pocket expenses are recorded as revenues, with related costs recorded as cost of revenues. We present revenues net of any taxes collected from customers and remitted to government authorities.

Revenues for the period ended March 31, 2023 in the amount of $793,458 was generated from the sale of the AirSCWO system and $8,000 was generated from the sale of treatability services. 

Revenues for the year ended December 31, 2022 in the amount of $2,952,020 was generated from the sale of the AirSCWO system and $63,501 was generated from the sale of treatability services. 

Stock-based Compensation

The Company has accounted for stock-based compensation under the provisions of ASC Topic 718 – “Stock Compensation” which requires the use of the fair-value based method to determine compensation for all arrangements under which employees and others receive shares of stock or equity instruments (stock options and common stock purchase warrants). The fair value of each stock option award is estimated on the date of grant using the Black-Scholes valuation model that uses assumptions for expected volatility, expected dividends, expected term, and the risk-free interest rate. Expected volatilities are based on historical volatility of peer companies and other factors estimated over the expected term of the stock options. The expected term of options granted is derived using the “simplified method” which computes expected term as the average of the sum of the vesting term plus the contract term. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for the period of the expected term.

Income Tax Policy

The Company accounts for income taxes using the liability method prescribed by ASC 740 - Income Taxes. Under this method, deferred tax assets and liabilities are determined based on the difference between the financial reporting and tax bases of assets and liabilities using enacted tax rates that will be in effect in the year in which the differences are expected to reverse. The Company records a valuation allowance to offset deferred tax assets if, based on the weight of available evidence, it is more-likely-than-not that some portion, or all, of the deferred tax assets will not be realized. The effect on deferred taxes of a change in tax rates is recognized as income or loss in the period that includes the enactment date.

Accounting for Uncertainty in Income Taxes

The Company follows the provisions of ASC Topic 740-10, “Accounting for Uncertainty in Income Taxes” which clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. This topic also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition. There were no uncertain tax positions as of March 31, 2023 and December 31, 2022.

Research And Development Costs

The Company’s research and development costs are expensed in the period in which they are incurred. Such expenditures amounted to $355,905 and $185,653 for the three months ended March 31, 2023, and 2022, respectively.

Earnings (Loss) Per Share

Earnings (loss) per share is computed in accordance with ASC Topic 260, “Earnings per Share” Basic weighted-average number of shares of common stock outstanding for the years ended March 31, 2023 and December 31, 2022 include the shares of the Company issued and outstanding during such periods, each on a weighted average basis. The basic weighted average number of shares common stock outstanding excludes common stock equivalent incremental shares, while diluted weighted average number of shares outstanding includes such incremental shares. However, as the Company was in a loss position for all periods presented, basic and diluted weighted average shares outstanding are the same, as the inclusion of the incremental shares would be anti-dilutive.  As of March 31, 2023 and December 31, 2022, there were the following potentially dilutive securities that were excluded from diluted net loss per share because their effect would be antidilutive: options for 13,025,000 shares of common stock and 1,250,000 warrants. 

Financial Instruments

The Company carries cash, accounts receivable, accounts payable and accrued expenses, at historical costs. The respective estimated fair values of these assets and liabilities approximate carrying values / useful lives of equipment and intangible assets due to their current nature.

Foreign Currency Translation

All assets and liabilities of the Companies’ locations whose accounts are denominated in foreign currency are translated into United States dollars at appropriate year-end current exchange rates.  All income and expense accounts of those locations are translated at the average exchange rate for each period.  The foreign currency translation amounts for the period ended March 31, 2023 and the year ended December 31, 2022 are included in accumulated comprehensive income on the consolidated statement of changes in equity.

Use Of Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates in the accompanying financial statements include the fair value of equity-based compensation, revenue, fair value of intangible assets, useful lives of intangible assets, capital raise transactions, and valuation allowance against deferred tax assets.

Recent Accounting Pronouncements

In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments, which amends guidance on reporting credit losses for assets held at amortized cost basis and available for sale debt securities.  For assets held at amortized cost basis, Topic 326 eliminates the probable initial recognition threshold in current GAAP and, instead, requires an entity to reflect its current estimate of all expected credit losses.  The allowance for credit losses is a valuation account that is deducted from the amortized cost basis of the financial assets to present the net amount expected to be collected.  For available for sale debt securities, credit losses should be measured in a manner similar to current GAAP, however Topic 326 will require that credit losses be presented as an allowance rather than as a write-down.  This ASU affects entities holding financial assets and net investment in leases that are not accounted for at fair value through net income. The amendments affect loans, debt securities, trade receivables, net investments in leases, off balance sheet credit exposures, reinsurance receivables, and any other financial assets not excluded from the scope that have the contractual right to receive cash. The amendments in this update are effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years.  The Company has completed its assessment on the impact of the adoption of the ASU on its financial statements, disclosure requirements and methods of adoption and noted that there is no impact at this time for our HTM investments and noted a small adjustment for the allowance for bad debt which has been recorded as of March 31, 2023. 

The Company considers the applicability and impact of all recently issued accounting pronouncements. Recent accounting pronouncements not specifically identified in our disclosures are either not applicable to the Company or are not expected to have a material effect on our financial condition or results of operations.

XML

Summary of Significant Accounting Policies (Tables)

3 Months Ended

Mar. 31, 2023

Summary of Significant Accounting Policies

Schedule of company held marketable securities

	Adjusted Cost		Unrealized Losses		Fair Value		Cash and Cash Equivalents		Current Marketable Securities		Non-Current Marketable Securities
Cash	$	9,153,161		—	$	9,153,161	$	9,153,161		—		—
Level 2:
U.S. Treasury securities	$	1,960,761	$	8,049	$	1,952,712	$	—	$	1,952,712		—
Total	$	11,113,922	$	8,049	$	11,105,873	$	9,153,161	$	1,952,712		—

	Adjusted Cost		Unrealized Losses		Fair Value		Cash and Cash Equivalents		Current Marketable Securities		Non-Current Marketable Securities
Cash	$	4,046,937		—	$	4,046,937	$	4,046,937		—		—
Level 2:
U.S. Treasury securities	$	1,963,432	$	18,968	$	1,944,464	$	—	$	1,944,464		—
Total	$	6,010,369	$	18,968	$	5,991,401	$	4,046,937	$	1,944,464		—

Schedule of accounts receivable allowance for credit losses

Name	Three Months Ending at March 31, 2023		Three Months Ending at March 31, 2022
Beginning balance	$	—	$	—
Current period provision		191		—
Write-offs		—		—
Ending Balance	$	191	$	—

Schedule of depreciation in property and equipment

	Period Ended March 31,
	2023		2022
Depreciation	$	9,525	$	235

XML

Inventory (Tables)

3 Months Ended

Mar. 31, 2023

Inventory

Schedule Of Inventory

Name	Balance at March 31, 2023		Balance at December 31, 2022
Raw materials	$	533,925	$	755,218
Work-in-process		1,254,094		905,492
Total	$	1,788,019	$	1,660,710

XML

Intangible Assets (Tables)

3 Months Ended

Mar. 31, 2023

Intangible Assets

Schedule Of Intangible Assets

Name	Estimated Life	Balance at December 31, 2022		Additions		Amortization		Balance at March 31, 2023
License agreement	17 Years	$	964,965	$	—	$	15,787	$	949,178
Patents	20 Years		85,057		2,705		1,123		86,639
Total		$	1,050,022	$	2,705	$	16,910	$	1,035,817

Name	Estimated Life	Balance at December 31, 2021		Additions		Amortization		Balance at December 31, 2022
License agreement	17 Years	$	1,028,114	$	-	$	63,149	$	964,965
Patents	20 Years		34,742		52,292		1,977		85,057
Total		$	1,062,856	$	52,292	$	65,126	$	1,050,022

Schedule Of Future Amortization Expense

	March 31,
	2023
2023	$	50,827
2024		67,769
2025		67,769
2026		67,769
2027		67,769
Thereafter		713,914
Intangible assets, Net	$	1,035,817

XML

Revenue (Tables)

3 Months Ended

Mar. 31, 2023

Revenue

Schedule Of unearned revenue activity

Name	Balance at March 31, 2023		Balance at December 31, 2022
Unearned revenue at beginning of year	$	200,109	$	—
Billings deferred		5,000		1,467,189
Recognition of prior unearned revenue		—		(1,267,080	)
Unearned revenue at end of year	$	205,109	$	200,109

Schedule Of revenue by type

Name	Balance at March 31, 2023		%			Balance at March 31, 2022		%
Equipment revenue	$	793,458		99	%	$	273,231		100	%
Service revenue		8,000		1	%		—		—	%
Total	$	801,458		100	%	$	273,231		100	%

Schedule Of unbilled accounts receivable

Name	Balance at March 31, 2023			Balance at December 31, 2022
Unbilled accounts receivable at beginning of year	$	918,164		$	—
Services performed but unbilled		793,458			918,164
Services billed		(39,168	)		—
Unbilled accounts receivable at end of year	$	1,672,454		$	918,164

XML

Stockholder Equity (Tables)

3 Months Ended

Mar. 31, 2023

Schedule Of Stock Option Activity

	Shares		Weighted Average Exercise Price		Aggregate Intrinsic Value		Weighted Average Remaining Contractual Life (Years)
Options outstanding at December 31, 2022		12,752,000	$	0.62	$	28,543,370		5.09
Granted		273,000		3.09		—		—
Exercised		—		—		—		—
Expired/forfeit		—		—		—		—
Options outstanding at March 31, 2023		13,025,000		0.67	$	52,705,860		4.93

	Shares		Weighted Average Exercise Price		Aggregate Intrinsic Value		Weighted Average Remaining Contractual Life (Years)
Options outstanding at December 31, 2021		12,300,000	$	0.37	$	30,504,000		5.62
Granted		360,000		3.33		—		—
Exercised		—		—		—		—
Expired/forfeit		—		—		—		—
Options outstanding at March 31, 2022		12,660,000		0.45	$	45,576,000		5.39

Schedule Of Warrant Activity

	Shares		Weighted Average Exercise Price		Aggregate Intrinsic Value		Weighted Average Remaining Contractual Life (Years)
Balance at December 31, 2022		1,250,000		2.50	$	450,000		1.96
Issued		—		—		—		—
Exercised		—		—		—		—
Balance at March 31, 2023		1,250,000		2.50	$	2,775,000		1.72

Stock Option [Member]

Schedule Of Stock Option Granted

	March 31, 2023			March 31, 2022
Dividend yield		0.00	%		0.00	%
Expected life	5.45 – 5.79 Years			5.65 – 5.75 Years
Expected volatility	35.24 – 35.88		%	37.73 – 39.18		%
Risk-free interest rate	3.58 – 3.97		%	1.44 – 2.12		%

XML

Summary of Significant Accounting Policies (Details) - USD ($)	Mar. 31, 2023	Dec. 31, 2022
Adjusted cost	$ 11,113,922	$ 6,010,369
Unrealized losses	8,049	18,968
Fair value	11,105,873	5,991,401
Cash and cash equivalents	9,153,161	4,046,937
Current marketable securities	1,952,712	1,944,464
Non-current marketable securities	0	0
U.S. Treasury Securities | Level 2
Adjusted cost	1,960,761	1,963,432
Unrealized losses	8,049	18,968
Fair value	1,952,712	1,944,464
Cash and cash equivalents	0	0
Current marketable securities	1,952,712	1,944,464
Non-current marketable securities	0	0
Cash
Adjusted cost	9,153,161	4,046,937
Unrealized losses	0	0
Cash and cash equivalents	9,153,161	4,046,937
Current marketable securities	0	0
Non-current marketable securities	0	0
Fair value	$ 9,153,161	$ 4,046,937

XML

Summary of Significant Accounting Policies (Details 1) - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Summary of Significant Accounting Policies
Beginning balance	$ 0	$ 0
Current period provision	191	0
Write-offs	0	0
Ending Balance	$ 191	$ 0

XML

Summary of Significant Accounting Policies (Details 2) - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Summary of Significant Accounting Policies
Depreciation	$ 9,525	$ 235

XML

Summary of Significant Accounting Policies (Details Narrative) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022
Research And Development Cost	$ 355,905	$ 185,653
Cash	2,696,107		$ 1,182,412
Allowance for doubtful accounts	191		0
Revenues from sale of treatability services	8,000		63,501
Revenues from sales	$ 793,458		$ 2,952,020
Warrants [Member]
Antidilutive Excluded from Computation of Earnings Per Share, Amount	13,025,000		1,250,000

XML

Liquidity, Capital Resources and Going Concern (Details Narrative) - USD ($)	3 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Liquidity, Capital Resources and Going Concern (Details Narrative)
Accumulated Deficit	$ 9,490,325	$ 7,849,982
Net Income (loss)	1,640,343
Net Cash Used In Operations	3,178,476
Working Capital	$ 13,966,018	$ 7,060,511

XML

Inventory (Details) - USD ($)	Mar. 31, 2023	Dec. 31, 2022
Inventory
Raw materials	$ 533,925	$ 755,218
Work-in-process	1,254,094	905,492
Total	$ 1,788,019	$ 1,660,710

XML

Intangible Assets (Details) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Intangible Assets, Net, Beginning balance	$ 1,050,022	$ 1,062,856
Additions	2,705	52,292
Amortization	65,126	16,910
Intangible Assets, Net, Ending balance	1,035,817	1,050,022
License Agreement [Member]
Intangible Assets, Net, Beginning balance	964,965	1,028,114
Additions	0	0
Amortization	15,787	63,149
Intangible Assets, Net, Ending balance	$ 949,178	$ 964,965
Estimated Life	17 years	17 years
Patents [Member]
Intangible Assets, Net, Beginning balance	$ 85,057	$ 34,742
Additions	2,705	52,292
Amortization	1,123	1,977
Intangible Assets, Net, Ending balance	$ 86,639	$ 85,057
Estimated Life	20 years	20 years

XML

Intangible Assets (Details 1) - USD ($)	Mar. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Intangible Assets
2023	$ 50,827
2024	67,769
2025	67,769
2026	67,769
2027	67,769
Thereafter	713,914
Intangible Assets, Net	$ 1,035,817	$ 1,050,022	$ 1,062,856

XML

Intangible Assets (Details Narrative) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Amortization expense	$ 16,910	$ 16,458
Duke University [Member]
Common shares issued, fair value	$ 1,073,529

XML

Revenue (Details) - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Revenue	$ 801,458	$ 273,231
Revenue percentage	100.00%	100.00%
Equipment revenue [Member]
Revenue	$ 793,458	$ 273,231
Revenue percentage	99.00%	100.00%
Service revenue [Member]
Revenue	$ 8,000
Revenue percentage	1.00%

XML

Revenue (Details 1) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Revenue
Unearned revenue beginning balance	$ 200,109	$ 0
Billings deferred	5,000	1,467,189
Recognition of prior unearned revenue	0	(1,267,080)
Unearned revenue ending balance	$ 205,109	$ 200,109

XML

Revenue (Details 2) - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2023	Dec. 31, 2022
Revenue
Unbilled accounts receivable at beginning of year	$ 918,164	$ 0
Services performed but unbilled	793,458	918,164
Services billed	(39,168)	0
Unbilled accounts receivable at end of year	$ 1,672,454	$ 918,164

XML

Stockholder Equity (Details) - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Granted	0
Weighted Average Exercise Price, beginning balance	$ 2.50
Weighted Average Exercise Price, ending balance	$ 2.50
Aggregate Intrinsic Value, beginning balance	$ 450,000
Aggregate Intrinsic Value, ending balance	$ 2,775,000
Options [Member]
Options Outstanding, beginning balance	12,752,000	12,300,000
Granted	273,000	360,000
Exercised	0	0
Expired/forfeited	0	0
Options Outstanding, ending balance	13,025,000	12,660,000
Weighted Average Exercise Price, beginning balance	$ 0.62	$ 0.37
Weighted Average Exercise Price, Granted	3.09	3.33
Weighted Average Exercise Price, Exercised	0	0
Weighted Average Exercise Price, Expired/forfeit	0	0
Weighted Average Exercise Price, ending balance	$ 0.67	$ 0.45
Aggregate Intrinsic Value, beginning balance	$ 28,543,370	$ 30,504,000
Aggregate Intrinsic Value, ending balance	$ 52,705,860	$ 45,576,000
Weighted Average Remaining Contractual Life (years) Beginning	5 years 1 month 2 days	5 years 7 months 13 days
Weighted Average Remaining Contractual Life (years) Ending	4 years 11 months 4 days	5 years 4 months 20 days

XML

Stockholder Equity (Details 1) - Options [Member]	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Dividend Yield	0.00%	0.00%
Minimum [Member]
Expected Life	5 years 5 months 12 days	5 years 7 months 24 days
Expected Volatility	35.24%	37.73%
Risk-free Interest Rate	3.58%	1.44%
Maximum [Member]
Expected Life	5 years 9 months 14 days	5 years 9 months
Expected Volatility	35.88%	39.18%
Risk-free Interest Rate	3.97%	2.12%

XML

Stockholder Equity (Details 2)	3 Months Ended
	Mar. 31, 2023 USD ($) $ / shares shares
Stockholder Equity
Balance At Beginning balance | shares	1,250,000
Shares Issued | shares	0
Shares Exercised | shares	0
Balance At Ending balance | shares	1,250,000
Weighted Average Exercise Price, beginning balance | $ / shares	$ 2.50
Weighted Average Exercise Price Issued | $ / shares	0
Weighted Average Exercise Price Exercised | $ / shares	0
Weighted Average Exercise Price, ending balance | $ / shares	$ 2.50
Aggregate Intrinsic Value, beginning balance | $	$ 450,000
Aggregate Intrinsic Value, issued | $	0
Aggregate Intrinsic Value, Exercised | $	0
Aggregate Intrinsic Value, ending balance | $	$ 2,775,000
Weighted Average Remaining Contractual Life(years), beginning balance	1 year 11 months 15 days
Weighted Average Remaining Contractual Life(years), ending balance	1 year 8 months 19 days

XML

Stockholder Equity (Details Narrative) - USD ($)	1 Months Ended	3 Months Ended
	Apr. 16, 2021	Mar. 31, 2023	Mar. 31, 2022	Dec. 31, 2022	Sep. 30, 2022	Jan. 12, 2022	Sep. 29, 2021	Oct. 30, 2020
Unrecognized compensation vesting period		four years
Unrecognized Compensation Expense, Unvested Options		$ 2,213,723
Warrants Outstanding Series 1		1,250,000
Preferred Stock Shares Authorized		50,000,000		50,000,000
Intrinsic value of outstanding warrants		$ 2,775,000
Common Stock Shares Authorized		200,000,000		200,000,000
Preferred Stock, Shares Issued		0		0
Warrants Outstanding		1,250,000		1,250,000	1,250,000
Warrant exercise Price		$ 2.50
Market Price		4.72
Preferred Stock, Par Value	$ 0.0001	0.0001		$ 0.0001
Common Stock Value Per Share		$ 0.0001		$ 0.0001
Common Stock, Shares issue		128,840,421
Stock-based Compensation		$ 214,924	$ 97,558
Research And Development		355,905	185,653
General And Administrative		$ 585,659	261,403
Equity Distribution Agreement [Member]
Sale of common stock shares		2,137,876
Consultant [Member]
Stock-based Compensation		$ 610,741
Research And Development		25,641	3,690
General And Administrative		$ 189,283	$ 93,868
374Water Former Stockholders [Member]
Common Stock, Shares issue	62,410,452
374Water, Inc. [Member]
Common Stock Value Per Share	$ 0.30
Series D Preferred Stock [Member]
Preferred Stock Shares Authorized						27,272	412,853
Preferred Stock, Shares Issued	440,125							1,000,000
Preferred Stock, Par Value								$ 0.0001
Liability For Preferred Stock Shares	$ 50,000
Gross Process From Private Placement Of Stocks	$ 6,551,691
Convertion Of Preferred Stock To Common Stock						1,363,149	20,642,667

XML

Related Party Transactions (Details Narrative)	3 Months Ended
	Mar. 31, 2023 USD ($)
Related Party Transaction, Expenses from Transactions with Related Party	$ 432,582
Related Party Cost	$ 446,081
Stock In Excess Percentage Of Outstanding Share	5.00%
Related Party Transactions [Member]
Related Party Transaction, Expenses from Transactions with Related Party	$ 514,399
Related Party Cost	$ 535,201

XML

Subsequent Events (Details Narrative) - Subsequent Events [Member]	1 Months Ended
	May 05, 2023 USD ($) shares
Maximum amount raised from equity offering of common stock shares	$ 100,000,000
At-the-market equity offering of shares of common stock, shares | shares	152,285
At-the-market equity offering of shares of common stock, amount	$ 717,835